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 Almost every cell in any organism contains the same genomic content.  
Different cell types, however, display strikingly different morphologies, behaviors 
and functions.  The central nervous system (CNS) provides an excellent example 
of cellular diversity.  The CNS develops as progenitor cells migrate and mature 
into thousands of distinct subtypes of neurons and supportive cells.  The cellular 
transformation from undifferentiated, pluripotent, embryonic stem cell to mature 
neuron is dictated by changing patterns of gene expression.  This process must 
be tightly regulated to ensure proper development.  Much of our understanding of 
the development of the human CNS has been gleaned from cell culture, 
specifically using human embryonic stem cells (hESC).   
hESC are derived from the inner cell mass of blastocyst-stage embryos; 
they can self-renew indefinitely and differentiate into any mature cell type in the 
body. The complex architecture of the brain cannot be re-created in a dish, but 
hESC can be directed to differentiate into specific neuronal subtypes.  
I have used RNA-Seq to analyze gene, transcription initiation site, and 
transcript expression patterns between the H9 and CT2 hESC lines. These 
experiments identified hundreds of genes and transcripts that are differentially 
expressed between the ES lines and among different culture systems.  I also 
Michael Jerome Horowitz – University of Connecticut, 2013 
used RNA-Seq to study transcriptome dynamics as H9 ES cells differentiate into 
spinal motor neurons.  These experiments demonstrated that, during neural 
differentiation, the expression levels of most genes stay relatively constant, while 
the number of genes and transcripts demonstrating divergent expression from 
hES cells increases throughout development. Consistent with previous work, a 
higher extent of alternative splicing was observed in neurons than in ES or 
differentiating cells. Semi-quantitative polymerase chain reaction (RT-PCR) 
validated expression changes for a subset of identified events.  More than 90% 
of tested, identified splicing events were successfully validated by PCR. 
CNS development involves regulation at the epigenetic, transcriptional, 
post-transcriptional, translational and post-translational levels.  Establishing a 
comprehensive understanding of the molecular events leading to neural 
differentiation of ES cells will require an integrated analysis of epigenetics, 
mRNA and small RNA expression, and a complete proteomic analysis.  These 
datasets and analyses represent a small piece of this incredible puzzle. 
  
 
 
Transcriptome Dynamics: a Global Approach to Characterizing the mRNA 
Populations of Human Embryonic Stem and Neural Lineage Cells 
 
 
Michael Jerome Horowitz, Ph.D. 
B.A. Swarthmore College, 2003 
 
 
 
 
 
 
 
 
A Dissertation 
Submitted in Partial Fulfillment of the 
Requirements for the Degree of 
Doctor of Philosophy at the 
University of Connecticut 
2013 
 
  
Copyright by 
Michael Jerome Horowitz 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013 
APPROVAL PAGE
Doctor of Philosophy Dissertation
Transcriptome Dynamics: a Global Approach to Characterizing the mRNA Populations
of Human Embryonic Stem and Neural Lineage Cells
Presented by Michael Jerome Horowitz, B.A.
Major Advisor  ______________________________________
                            Brenton R. Graveley
Associate Advisor ______________________________________
                             Gordon G. Carmichael
Associate Advisor ______________________________________
                             Stormy Chamberlain
Associate Advisor ______________________________________
                             Xue-Jun Li
Associate Advisor ______________________________________
                               Blanka Rogina
Associate Advisor ______________________________________
                              Ren-He Xu
University of Connecticut
2013
 
                                                                     ii 
 iii 
ACKNOWLEDGMENTS 
 
 I would first like to thank my thesis advisor, Brent Graveley.  He has 
provided a nurturing environment for me to begin my career as a scientist.  He 
has been very supportive of my efforts and has constantly encouraged me to 
take my research project in new and interesting directions.  Without his 
mentorship, I would not be where I am today.  I also want to thank my thesis 
committee: Gordon Carmichael, Stormy Chamberlain, Xue-Jun Li, Blanka Rogina 
and Ren-He Xu for their guidance and insightful suggestions. 
 My girlfriend Kelly Kass has given me the utmost support as I have made 
my way through graduate school.  If I had a tough day in lab, she would always 
know the right thing to say to encourage me and keep my spirits up.  She is an 
amazing partner and I don’t know what I would do without her. 
 I would like to thank my family and friends for their help, as well.  My 
mother, Carol Grodzins, and father, Paul Horowitz, provided me with a model for 
true professionalism.  I have them to thank for helping me develop a work ethic 
that has guided me through my long academic journey.  My brother Jake is 
always there with a motivating talk when I felt things were stagnant.  In my time 
at UConn, I have developed strong friendships, and without the friends I’ve made 
here, I would have been miserable – not to mention extremely lonely during 
lunch.  Finally, the current and past members of the Graveley lab have been 
unbelievable supportive and helpful toward me throughout my time here.  It has 
truly been a wonderful experience in all ways. 
 iv 
TABLE OF CONTENTS 
Copyright Notice…………………………………………………………………….….i 
Approval Page…………………………………………………………………….……ii 
Acknowledgments………………………………………………………………….….iii 
List of Tables……………………………………………………………………...…...vi 
List of Figures………………………………………………………………………….vii 
Chapter 
1. Transcriptome dynamics: a global approach to characterizing the 
mRNA populations of human embryonic stem and neural lineage  
cells…………………………………………………………………………..1 
I. Genomics and development……………………………………….1 
i. Evolution of gene expression analysis……………………2 
ii. Advances in sequencing technology……………………...4 
II. Development of the central nervous system (CNS)……………..7 
i. Early studies in neural patterning………………………….8 
ii. Signaling pathways in early neural patterning……………9 
III. Embryonic stem cells (ESC)……………………………………...14 
i. Derivation and potential…………………………………...14 
ii. Recapitulation of neural differentiation…………………..18 
IV. Coordinated layers of gene regulation………………………..…26 
V. Alternative splicing……………………………………..................43 
i. Importance and preponderance………………………….43 
ii. Feedback on regulatory layers…………………………...47 
 v 
iii. Tissue-specific AS and its role in neuronal 
differentiation……………………………………………....51 
iv. Exploiting next-gen sequencing to survey alternative 
splicing……………………………………………………...52 
v. The future of the field……………………………………...62 
2. Transcriptome analysis of human embryonic stem and neural lineage 
cells………………………………………………………………………….67 
3. Differential transcription and alternative splicing patterns between H9 
and CT2 hES cells: establishing the basal hESC transcriptome……144 
4. A summary of findings, conclusions and prospects for future 
research…………………………………………………………………...193 
5. Works Cited……………………………………………………………….202 
 
 vi 
List of Tables 
 
Table 2.1 Summary of MISO analysis of alternative splicing patterns in the neural 
timeseries……………………………………………………………..………110 
Table 3.1 Summary of MISO analysis of alternative splicing patterns in the hES 
comparison……………………………………………………………………181 
 
 
 vii 
List of Figures 
 
Figure 1.1 The classical, “default” model of neural induction……………………..11 
Figure 1.2 Signaling in early neural induction………………………………………20 
Figure 1.3 Dorso-ventral and rostro-caudal neuroectoderm patterning………….23 
Figure 1.4 Model of the meshwork of gene regulatory layers………………….....28 
Figure 1.5 The core hESC transcriptional network……………………………...…32 
Figure 1.6 Effects of Pax6 overexpression and knockdown in ES cells on neural 
differentiation capability………………………..………………………...34 
Figure 1.7 Coordinated, “coherent” feed-forward regulation of Dnmt3 by master 
hES transcription factors…….………………………………………......38 
Figure 1.8 “Incoherent” feed-forward regulation by master hES transcription 
factors on Lefty1/2……………………………....…………………...…...41 
Figure 1.9 Schematic representing the most common types of alternative splicing 
events………………………………………………………………………45 
Figure 1.10 Sex-specific splicing patterns of three major Drosophila sex-
determination genes……..……………………………………………….49 
Figure 1.11 Distinct effects of two Pax6 splice variants on hES differentiation…54 
Figure 1.12 Splicing analysis of Slc25A3 gene by mRNA-Seq………………...…57 
Figure 1.13 HITS-CLIP analysis of NOVA tag locational effect on splicing 
patterns…………………………………………………………………….60 
Figure 1.14 Uneven RNA-Seq coverage across GAPDH exons………...............64 
 
 viii 
Figure 2.1 Characterization of motor neuron differentiation cultures…………….77 
Figure 2.2 Unsupervised hierarchical clustering of differentially expressed genes 
in the neural timeseries………………………………………………......80 
Figure 2.3 RT-PCR validates observed differential expression patterns..........…83 
Figure 2.4 Panther pathway analysis of differentially expressed gene 
clusters……………………………….…………………………………….93 
Figure 2.5 RNA-Seq analysis of Lin28 expression…………………………….......99 
Figure 2.6 Unsupervised hierarchical clustering of WNT, TGF-beta, FGF, Notch, 
Integrin and JAK/STAT signaling elements……..……………………101 
Figure 2.7 Unsupervised hierarchical clustering of signaling pathways………..105 
Figure 2.8 Analysis of differential gene expression in regionalized late neural 
precursor (LNP) cells……………………………………………………109 
Figure 2.9 Percentage spliced in (PSI) scatterplots for all detected splicing events 
of each subtype………………………………………………………….115 
Figure 2.10 Splicing pattern correlation heatmap for 31,479 cassette exon events 
detected in any neural timeseries sample…………………………….119 
Figure 2.11 Cassette exon splicing heatmap and analysis of an identified 
significant splicing change in Ralgps2………………………………...121 
Figure 2.12 RNA-Seq analysis and RT-PCR validation of identified splicing and 
transcription initiation site changes……….........…………………..…125 
 
Figure 3.1 Characterization of newly-derived CT2 human embryonic stem cell 
line…………….….........…………………..….........……………………151 
 ix 
Figure 3.2 Differentiation characteristics of hES cells in the three major culture 
conditions………………………………………………………...………155 
Figure 3.3 Expression overview of H9 and CT2 cells growing in the three major 
culture conditions………………………………………………….…….159 
Figure 3.4 Unsupervised hierarchical clustering of highly enriched gene 
expression in H9 and CT2 cells……….……………………………….161 
Figure 3.5 Highly enriched gene expression in CT2 cells………………….........163 
Figure 3.6 Highly enriched gene expression in H9 cells……………………....…167 
Figure 3.7 Culture condition-dependent gene expression analysis………….....172 
Figure 3.8 Examples of culture condition-dependent gene expression…....…..175 
Figure 3.9 Identification of a Snrpn cassette exon that is differentially spliced 
between H9 and CT2 cells……………………………………………..184 
 1 
 
CHAPTER 1 
Transcriptome Dynamics: a Global Approach to Characterizing 
the mRNA Populations of Human Embryonic Stem and Neural 
Lineage Cells 
 
Genomics and Development 
 Almost all cells in a given organism contain the same genomic content.  
However, the morphologies, behaviors and gene expression milieus of various 
cell types are strikingly diverse, and the compartmentalization of different 
homeostatic functions to different organs, tissue types and cells is a hallmark of 
higher complexity organisms.  Understanding the gene regulatory mechanisms 
that are active in various cells and cell lineages at different stages of 
development is a major goal of the field of modern genomics. With the explosion 
of the sequencing field, many organisms’ entire genomes are available.  It is 
important to note, however, that the DNA sequence, the “code of life” consisting 
of A’s, T’s, C’s and G’s, is not very informative on its own.  Even understanding 
the structure of DNA elements – genes – only tells a small part of the story.  This 
is illustrated by the fact that humans only have roughly 4 times as many genes as 
budding yeast, and roughly the same number as the flatworm C. elegans (Nilsen 
and Graveley, 2010).  The human body, however, is obviously much more 
complex than these organisms; it has become clear that much of the “missing” 
protein diversity comes from the process of alternative RNA processing, including 
alternative splicing (AS) (Nilsen and Graveley, 2010).  
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Discovering and detailing the transcriptome of a cell – the protein-coding 
messenger RNAs (mRNAs) and non-coding RNAs – is crucial to developing our 
understanding of gene regulatory networks.  By focusing on the DNA elements 
that are actively being transcribed, we can establish a “snapshot” of the 
expression environment of different cells, tissues, or organs at various stages of 
development, at different steps of the cell cycle, or in diseased states.  Rapidly 
improving technology allows us to dig deeper by the month, yielding more and 
more data and more powerful analytical tools. 
 
Evolution of Gene Expression Analysis 
One of the earliest approaches to transcriptome analysis, using expressed 
sequence tags (ESTs), generates cDNA libraries from reverse-transcribed mRNA 
populations (Adams et al. 1991).  These cDNAs are then cloned into vectors, 
transformed into bacterial “factories,” amplified and sequenced at random to 
generate an index of genes expressed in the original organism, tissue, etc.  By 
comparing the proportion of sequence reads corresponding to ESTs from 
different genes in, for instance, healthy liver cells vs. hepatocellular carcinoma, 
this technique could provide compendia of gene expression for comparison in 
different states.  EST-based approaches, however, are sub-optimal, as the 
sequence is often of low quality – especially at both ends of reads – and these 
sequence fragments tend to lie in 3’ ends of genes; therefore, any alternative 
structures derived from the 5’ ends of genes are invisible to EST tiling (Yeo et al. 
2007).  Additionally, bacterial cloning constraints have a major effect on EST 
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sequence representation (Mortazavi et al. 2008), and vector and linker sequence 
contamination is common.  Redundancy, under-representation of rare transcripts, 
and high error rates represent additional confounding factors (Nagaraj et al. 
2006); the process is also slow and resource-intensive (Graveley, 2008).  Similar 
issues are encountered with serial analysis of gene expression (SAGE).  SAGE 
involves collection of mRNA molecules, followed by reverse transcription to form 
cDNA; cDNA molecules are cleaved at their 3’ ends, using restriction enzymes, 
to liberate ~20 nt “tags.”  Many tags are ligated together and sequenced in a long 
chain.  The numbers of times a given tag is sequenced can be taken as a 
measure of the corresponding gene’s expression level (Saha et al. 2002).  This 
technique results in even more extreme 3’ bias, meaning alternative 5’ end 
structures will be missed.  Multiple restriction enzymes must be used to ensure 
adequate cleavage across genes.  Sequencing costs, at the time of SAGE’s 
introduction, were prohibitively high, preventing its use in genome-wide studies in 
complex organisms like humans.  While these approaches were effective for 
early cataloguing of cell-, tissue-, disease- and organism-specific gene 
expression, they are largely ineffective for detailing complex patterns of RNA 
processing like AS. 
The advent of microarray technology dramatically expanded the 
throughput of gene expression analysis.  Microarrays are small chips with a lawn 
of pre-fabricated DNA probes; fluorescently labeled RNA samples are hybridized 
to the array, and the assumption is that the probes that “light up” represent 
actively transcribed genes.  So-called tiling arrays – with DNA probes from every 
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~35 bp across the genome – proved to be an effective method of gene 
expression interrogation (Graveley, 2008).  Furthermore, microarray technology 
allowed detection of specific splicing events by hybridization to splice junction 
probes.  Microarrays, however, carry many inherent drawbacks of their own. 
Cross-hybridization to related sequences cause false-positives, results can vary 
dramatically from lab to lab or even run to run, and signal:noise ratio issues 
cause difficulties in detecting low-abundance transcripts (Wold and Myers, 2008).  
The tiling arrays mentioned above largely ignore splice junctions; the 
experiments are also expensive and difficult to analyze (Sultan et al. 2008).  As 
microarray technology has improved, the physical limitation of probe numbers 
has been relaxed, but all microarray experiments are limited to sets of defined 
oligonucleotide probes – one will only detect events that are already known or 
predicted, making discovery of novel transcripts impossible (Yeo et al. 2007; 
Graveley, 2008; Wold and Myers, 2008; Sultan et al. 2008). 
 
Advances in Sequencing Technology 
 The field of DNA sequencing was essentially born in 1975, with the 
seminal work of Sanger and Coulson at the University of Cambridge, describing 
the use of oligonucleotide primers and E. coli DNA polymerase I to generate 
sequences from the bacteriophage φX174 (Sanger and Coulson, 1975).  Two 
years later, the “Sanger sequencing” method had been revised, incorporating the 
use of radioactively labeled di-deoxynucleotide phosphates (ddNTPs) with DNA 
polymerase, to rapidly sequence the full phage genome (Sanger et al. 1977; 
 5 
Sanger et al. 1977).  Also in 1977, Allan Maxam and Walter Gilbert demonstrated 
their own method, based on chemical modification of DNA and subsequent 
cleavage at specific bases (Maxam and Gilbert, 1977).  As the Maxam & Gilbert 
method requires more intensive preparation of DNA, the Sanger method quickly 
became the sequencing technique of choice. 
 In order to query large genomes, the process of sequencing required 
scale-up.  Lynx Therapeutics developed the first “high-throughput” (AKA “next-
gen”) sequencer in the 1990’s.  Their technique was similar to SAGE; briefly, 
restriction enzymes are used to cleave mRNA populations, which are then 
converted to cDNA and cloned onto microbeads.   A series of labeled adapter 
molecules are hybridized to interrogate the cDNA “tags,” generating roughly a 
million 16-20 “signature sequences” that can be used to identify expressed 
mRNA molecules (Brenner, 2000).  This method had the advantage of much 
higher throughput than SAGE but suffered from the same drawbacks associated 
with that technique, detailed above.   
Two additional next-gen sequencing (“NGS”) methods were introduced in 
2005: 454 Life Sciences introduced their pyrosequencing machine, in which 
nucleotide incorporation into the sequencing reaction triggers a measurable burst 
of light (Margulies et al. 2005), and a Harvard University laboratory published a 
method based on multiplex sequencing-by-ligation to mate-paired libraries 
embedded in polymerase colonies (Shendure et al. 2005), or “polonies.”  454 
sequencing (now owned by Roche) generates intermediate (~200-400 bp) reads 
and can be highly informative for mRNA analysis (Weber et al. 2007).  The 
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sequencing-by-ligation technique was incorporated into the ABI SOLiD platform, 
another major player in NGS (Cloonan et al. 2008; Tang et al. 2009).  Soon 
thereafter, Lynx Therapeutics merged with Solexa, another sequencing 
company, and in 2006 Solexa released the first generation of their Genome 
Analyzer.  The GA I could generate 1 Gb of sequence per run.  Illumina 
purchased Solexa in 2007 and has continued to improve upon the technology; 
the newest machine (“HiSeq 2000”) can generate upwards of 600 Gb per run 
(Illumina, 2011), and is considered particularly attractive for expression studies, 
owing to its exceptional coverage and depth (Marioni et al. 2008).  The NGS 
platforms have dramatically lowered the costs of sequencing and making it 
possible for individual labs to generate gigabases (109 bp) of sequence in a 
matter of days (Pepke et al. 2009).  While the intended purpose of NGS was in 
genome sequencing, many other applications have been developed that have 
greatly increased the technique’s power and attractiveness to researchers.  
Chromatin immunoprecipitation can be coupled to deep sequencing (Vermuelen 
et al. 2010) (“ChIP-seq”), opening doors for new research into consensus protein 
binding sites, transcription factor targets and chromatin structure.  Small RNA 
species can be selectively queried with sensitivity never before achievable 
(Marson et al. 2008).  Finally, deep sequencing is an ideal platform for studying 
protein-coding gene expression (Graveley, 2010; Wold and Myers, 2008; Sultan 
et al. 2008, Marioni et al. 2008, Wu et al. 2009)  (“mRNA-seq”); with a reliable 
reference genome, millions of individual sequence reads – depending on the 
readlength – can be uniquely mapped back to genes and transcripts, essentially 
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giving an unambiguous, digital readout.  Novel genes, exons and isoforms can 
be identified, as sequencing experiments require no prior knowledge of sequence 
identity (Marioni et al. 2008).  The sensitivity of NGS is greater than that of 
microarray, as is the dynamic range (Graveley, 2010; Marioni et al. 2008) (range 
of minumum to maximum signal).  Isoforms and alternative exons that are 
extremely similar in sequence can be distinguished more clearly than with 
microarray, and software programs for isoform modeling (Trapnell et al. 2009) 
and estimating relative transcript abundance are available, whose algorithms 
continue to evolve in elegance and complexity (Trapnell et al. 2010).  
Additionally, a proportion of all reads – dependent on readlength – crosses exon-
exon junctions, providing direct evidence for splicing events without the caveats, 
mentioned above, associated with hybridization (Sultan et al. 2008; Pepke et al. 
2009; Wu et al. 2009).  mRNA-seq datasets have shown high correlation with 
EST and microarray data with respect to splicing analysis (Sultan et al. 2008; Wu 
et al. 2009; Pan et al. 2008). 
 
Development of the Central Nervous System (CNS) 
The development of the human central nervous system is a highly 
complex process in which a multitude of cellular subtypes differentiate from 
migrating neural stem cells originating from the neural tube.  As these neural 
stem cells migrate, they respond to spatially- and temporally-restricted 
combinations of signals to give rise to populations of progenitors that are primed 
to develop into regional subtypes of neuronal and glial (support) cells (Gaspard 
 8 
and Vanderhaeghen, 2010).  Progenitors and more terminally differentiated cells 
themselves are sensitive to distinct signals that act to guide them to their final, 
appropriate positions in the mature CNS, ensuring the proper functioning of 
neuronal circuitry (Gaspard and Vanderhaeghen, 2010).  This process depends 
on the interplay of a vast network of molecular, genetic and epigenetic 
mechanisms, including transposons, alternative splicing, RNA editing, chromatin 
structure, and post-translational modifications (Yeo et al. 2007).  Elucidating the 
events that lead to the generation of this tissue heterogeneity is important in our 
basic understanding of human neural development and also in our quest to 
develop new, effective therapies for neurodegenerative conditions.   
 
Early Studies in Neural Patterning 
 The first step toward understanding how the central nervous system 
develops came from the pioneering experiments of Spemann and Mangold, 
performed over 80 years ago.  They found a morphologically distinct group of 
mesodermal cells at the dorsal lip of the blastopore in gastrula-stage frog 
embryos.  When transplanted to the ventral region of another organism, in an 
area that would normally form epidermis (an ectoderm-derived tissue, like the 
CNS), these cells followed their normal path, forming axial mesoderm.  To their 
surprise, however, the ectodermal tissue surrounding the transplant was induced 
to form an entire, secondary nervous system (Spemann and Mangold, 2001). 
 Similar experiments in other organisms, including amniotes, demonstrated 
similar functions for the homologous node structures.  When the ectodermal cap 
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was cultured in vitro, it gave rise to epidermal cells.  Dissociated cells, however, 
differentiated into neural tissue.  These results indicated that early signaling 
between ectodermal cells suppresses neural differentiation.  After more than 50 
years, researchers discovered that TGF-b family members, including BMP 
proteins, serve as the paracrine signals. Bmp mRNA is expressed ubiquitously in 
the blastula, but in early gastrulation, these molecules are rapidly cleared from 
the future neural territory, indicating that cells enter the neural lineage by default, 
but BMP signaling blocks this progression.  Indeed, the organizer region 
expresses BMP inhibitors (Wilson and Edlund 2001, Sasai et al. 1995) (Figure 
1.1). 
 
Signaling Pathways in Early Neural Patterning 
 The picture described above is, unfortunately, not so simple.  Further work 
made it clear that there are additional signaling pathways at play in this process.  
FGF pathway signaling has been implicated as an important element of neural 
induction, but contradictory results in different experiments has made its 
contribution less clear, possibly due to distinct effects of the different FGF 
receptor molecules on the process (Hongo et al. 1999).  Moreover, WNT 
signaling seems to be important in neural differentiation, as overexpression of 
Wnt mRNA in one-cell embryos leads to an excessively dorsalized embryo with 
ectopic neural tissue.  Wnt overexpression in blastula-stage embryos, however, 
leads to suppression of neural character (Wilson and Edlund, 2001).   
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Figure 1.1.  The classical, “default” model of neural induction.  In the blastula, 
Bmp mRNA is ubiquitously expressed by ectoderm, promoting epidermal and 
suppressing neural fate.  During gastrulation, the organizer (node) forms and 
secretes BMP inhibitors like Noggin.  This inhibition leads to acquisition, in a 
gradient dependent manner, of neural fate and differentiation into neural tissue.  
Excerpted from Wilson and Edlund, 2001. 
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Developmental biologists were working under the presumption that this early 
ectodermal tissue was a homogenous mass of undifferentiated plasm, and that 
the organization into epidermal and neural regions occurred under the guidance 
of the organizer during gastrulation.  There was evidence, however, that this is 
not the case.  Early neural markers start to show restricted dorsal expression 
before gastrulation commences (Kroll et al. 1998); furthermore, BMP effectors’ 
expression is ventralized before the organizer forms (Wilson and Edlund, 2001).  
 Work in amniotes has helped to build on the original findings in 
amphibians.  The chick/mouse organizer/node structure, like in Xenopus, can 
induce ectopic neural tissue when transplanted.  Despite its sufficiency in 
inducing ectopic neural development, experiments in mutants that fail to form an 
organizer demonstrated that it is not necessary for the formation of a neural plate 
(Wilson and Edlund, 2001).  This fact led to the conclusion that there must be 
another source of neural-inducing signal, and that neural specification may begin 
before formation of the organizer.  This idea has been fleshed out using chick 
embryos, whose medial and lateral aspects are distinguishable through 
differential gene expression even at the blastula stage.  Medial cells will, in the 
absence of other signals, give rise to neural tissue while lateral cells are specified 
to become epidermis.  As gastrulation proceeds, however, cells become 
committed, meaning they will no longer respond to signals that would induce 
alternate cell fates (Wilson and Edlund, 2001). 
 Removal of Bmp mRNA from the prospective neural plate in the blastula 
seems to be a common initial event in neural induction.  Bmp is excluded from 
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this region in amniote and anamniote embryos (Wilson and Edlund, 2001).  In 
chick embryos, this step appears to be dependent on Fgf3 – Fgf3 mRNA is 
expressed in the primitive medial ectoderm, and expression of FGF receptor 
inhibitors leads to maintenance of Bmp expression and blockade of neural 
induction (Wilson et al. 2000).  Expression of BMP antagonists can restore neural 
fate in cells exposed to low, but not high, levels of FGF receptor inhibition, 
indicating that FGF works through at least 2 distinct mechanisms: clearance of 
Bmp mRNA (requiring high FGF signaling) and a non-Bmp-related pathway, 
requiring at least a low level of FGF signaling (Wilson et al. 2000).   
 Fgf3 is also expressed, however, in the primitive lateral ectoderm (these 
cells will go on to form epidermal tissue), where Bmp mRNA expression is 
maintained through gastrulation.  Exogenous FGF expression is unable to induce 
neural cell fate in this context (Wilson and Edlund, 2001).  It is believed that 
these cells are prevented from responding to FGF by another signal: Wnt.  
Wnt3A and Wnt8A are both expressed in lateral, but not medial, epiblast cells in 
chick blastulas.  Forced expression of these mRNA molecules in medial epiblast 
cells block neural and promote epidermal differentiation (Wilson et al. 2000).  
Further, Wnts demonstrate the same concentration-dependent effects on BMP 
signaling as FGF inhibitors – at low levels of Wnt expression, BMP antagonists 
can restore neural fate in these medial epiblast cells, but have no effect in the 
context of high-level Wnt signaling.  Additionally, Wnt antagonist molecules block 
epidermal and induce neural cell fate in prospective epidermal cells; this effect is 
lost when the cells are exposed to BMP signals (Wilson et al. 2000). 
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 Without the use of the animal models outlined above, it would not have 
been possible to establish the substantial knowledge of the events and pathways 
leading to CNS development. Spemann and Mangold’s early studies using tissue 
transplants to more recent fate-mapping and transgenic animal studies provided 
an extraordinary understanding and appreciation for the importance of tightly 
delineated expression of transcription factors in tissue development (e.g. 
establishment of the midbrain-hindbrain border) (Rhinn et al. 2009).  Global, 
stage- and tissue-specific knockouts of genes – both coding and non-coding – 
are extremely powerful methods for examining how disruptions of single genes 
can affect the developmental potential of whole tissues and organisms. Given 
that these types of experiments are dependent on genetic manipulation, 
sacrificing of pregnant mothers and analysis of partially developed fetal tissue, 
however, ethical/moral concerns preclude the possibility of using these 
techniques in human subjects.  Most of our knowledge of human neural 
development, therefore, comes from extrapolation from animal models and use 
of in vitro culture systems. 
 
Embryonic Stem Cells (ESC)  
Derivation and Potential 
Embryonic stem cells (ESC) are derived from the inner cell mass of 
developing blastocyst embryos, and give rise to all of the developed tissues of 
the embryo proper.  They have been derived from many organisms, including 
mice, non-human primates and humans (hESC). Dozens of hESC lines have 
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been derived in various institutes and laboratories across the world, but the H9 
line, derived at the University of Wisconsin’s WiCell Institute, is one of the most 
commonly used; experiments employing the H9 line are the most-cited works.  
As these cells retain their pluripotency in vitro, they can be directed to 
differentiate into numerous mature cell types, and researchers, through 
combinations of inductive signals, have succeeded in establishing highly 
reproducible protocols to generate many diverse cells, from epidermal skin cells 
(Metallo et al. 2008) to pancreatic neuroendocrine cells (D’Amour et al. 2006), to 
functional motor neurons that form synapses and fire action potentials (Li et al. 
2005).  Different combinations of inductive signals, and the timing of their 
introduction, can subtly or dramatically alter phenotypes and cellular subtypes of 
differentiated cells through activation of different genetic programs.  These 
characteristics make ESC an ideal system for studying differentiation and human 
embryonic development.  There is great hope that cells generated through 
directed differentiation will be able to be transplanted into diseased patients as a 
breakthrough therapy for previously intractable diseases.  Researchers have 
achieved success in correcting erythrocytes in mice with a humanized version of 
sickle cell anemia (Hanna et al. 2007), and have demonstrated that human 
neural progenitor cells injected into Parkinsonian rats migrate to affected areas of 
the brain and differentiate into functional dopaminergic neurons (Ben-Hur et al. 
2004). 
Concurrently with the development of directed differentiation techniques, 
stem cell experts have pioneered methods to induce the reprogramming of 
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mature human cell types back into an embryonic stem cell-like state (Takahashi 
et al. 2007; Yu et al. 2007): the induced pluripotent stem cells (iPSC).  This 
discovery allows the potential to create pools of patient-specific stem cells – we 
could theoretically take cells from a patient with a genetic disease, reprogram 
them into iPSC, fix the mutation with gene therapy, differentiate the cells into 
progenitors for the damaged cell type, and inject the progenitors as cell-based 
therapy without the need for lifelong immunosuppression (Amabile & Meissner, 
2009).  This would truly shift the paradigm of modern medicine.  Thus, in addition 
to our basic knowledge of human development, understanding the specific 
genetic cascades induced by these signals could have important implications for 
regenerative medicine. 
In order to harness the incredible potential of ESC and iPSC, we must be 
able to faithfully and fully recapitulate the complicated process of development 
that occurs in vivo during human embryogenesis, and this will certainly involve 
more than activating a handful of transcription factors.  There are major efforts 
underway to discover and detail the many interweaving layers of regulatory 
mechanisms in place for maintaining self-renewal and triggering differentiation.  
Many impressive findings have emerged from these studies, and it seems clear 
that the stem cell “molecular niche” is a delicate balance between factors 
contributing to renewal vs. differentiation.  This balance is achieved by the 
conflicting actions of factors acting on epigenetic, transcriptional, post-
transcriptional, translational and post-translational levels. 
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While tremendous progress has been made since the original derivation of 
embryonic stem cells, the precise mechanisms regulating their proper function 
and growth control remain elusive.  There are a number of different culture 
systems available for ESC culture, including some that involve co-culture with 
animal cells.  While it is understood that the different chemicals, growth factors, 
and environmental conditions affect expression patterns in these different 
settings, there have been no high-resolution, genome-wide analyses of 
transcriptome expression between the culture conditions.  Additionally, while 
recent work indicates that overall patterns of gene expression and epigenetic 
landscapes are similar between ESC and iPSC (Bock et al. 2011), there are still 
questions regarding whether these cells actually behave the same way in all 
applications.  Stem cells share some important characteristics with cancer cells – 
importantly, their unlimited growth potential through their ability to self-renew 
through asymmetric cell divisions.  There are a number of proto-oncogenes 
active in stem cells (one of the earliest protocols for the induction of iPSC 
involved retroviral transduction of the proto-oncogene c-Myc) (Takahashi et al. 
2007), and it is absolutely crucial to understand the control of these genes’ 
expression patterns before we begin injecting them into patients.  In fact, in 
countries that currently allow stem cell transplantation-based therapy, there is a 
high rate of mortality during the procedure itself, not to mention development of 
tumors from the injected stem cells (Amariglio et al. 2009). 
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Recapitulation of Neural Differentiation 
The discoveries described above were all crucial to our understanding of 
how a few basic morphogens can be used to pattern a highly complex system 
like the CNS.  Surprisingly, these signals and basic pathways are conserved in 
amniote and anamniotic organisms.  Further work in mice and mouse and human 
ES cells indicate that, even in the most complex organisms’ CNS, these same 
pathways are intact and utilized.   
On a macro scale, there are certain patterns that emerge from 
comparative studies of neural development.  The neural induction of embryonic 
tissue, thought of as the “default” pathway, results from organizer secretion of 
BMP inhibitors (Wilson and Edlund, 2001).  FGF signaling and Wnt inhibition also 
play a role.  Work by a number of labs has demonstrated that the same 
sequential action of BMP and WNT inhibitors along with FGF agonists control 
specification and regional patterning in mice in vivo and in vitro, and many of 
these discoveries have held in human culture systems, as well (Gaspard and 
Vanderhaeghen, 2010), providing support for the “default” model of differentiation 
seen across amniotes and anamniotes (Figure 1.2).  Experiments performed in 
vivo in mice have lent credence to a model whereby FGF and IGF pathway 
signaling, in combination with Wnts, exert their effects on neural induction by 
regulating Smad1 (Gaspard and Vanderhaeghen, 2010; Pera et al. 2003), a 
crucial downstream effector in the BMP signaling cascade.  Further, the classical 
view of default neural induction holds that the fate of these “primitive”  
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Figure. 1.2.  Signaling in early neural induction.  A combination of FGF agonist 
and BMP and WNT antagonist signaling leads to early neural induction. These 
cells, by default, acquire an anterior identity.  There is strong evidence that these 
pathways are intact in embryos in vivo and in vitro, in mouse and human ES 
cells. Adapted from Gaspard and Vanderhaeghen, 2010. 
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differentiating cells is to form anterior neural structures (Wilson and Edlund, 
2001), while further signaling serves to posteriorize or caudalize the cells 
destined to form more posterior structures, like the midbrain (FGF8) or spinal 
cord (retinoic acid; RA) (Gaspard and Vanderhaeghen, 2010).  Again, work in ES 
cells has confirmed this pattern: ES cell-derived neural progenitors initially 
express markers typical of anterior neurons (Li et al. 2005).  Signaling by sonic 
hedgehog (SHH) and/or RA are required to drive these progenitors toward more 
posterior phenotypes; cells destined to remain anterior-type neurons are 
protected from these morphogens by antagonizing signals (Gaspard and 
Vanderhaeghen, 2010).  Dorso-ventral patterning, likewise induced by gradients 
of morphogens and antagonists, is controlled by the same factors in vivo and in 
vitro (Figure 1.3).   
 Perhaps most remarkably, the temporally dependent aspects of CNS 
formation and diversity are conserved in culture.  Both in vivo and in vitro, in most 
cases, progenitor cells first form neurons, but as they age, their gliogenic 
capacity increasingly predominates.  Researchers took advantage of this 
behavior in cultured cells to perform gene expression and RNAi screens, 
identifying the roles of specific transcription factors, COUP-TFI and II, in the 
epigenetic modification of genes involved in the neuro-gliogenic switch (Naka et 
al 2008).  This represented the first demonstration of conserved, cell-intrinsic 
factors controlling temporal patterning.  Similar experiments uncovered the role 
of CSL and Notch signaling in this process (Gaspard and Vanderhaeghen, 2010).  
Temporal control of expression is at the heart of vertebrate CNS diversity,  
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Figure 1.3.  Dorso-ventral and rostro-caudal patterning (i.e. “regionalization”) of 
neuroectodermal tissue is effected by gradients of secreted signals, including 
retinoic acid (RA), FGF and members of the WNT signaling pathway (DKK, 
WNTs).  This embryonic process is recapitulated in ES cell culture.  Adapted 
from Gaspard and Vanderhaeghen, 2010. 
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especially in complex structures like the cortex.  Work has shown that a neuron’s 
birthdate can dictate its migration pattern into the developing cortex: older 
neurons settle in deeper pyramidal layers, while younger neurons migrate past 
these cells to take root in the upper cortical layers.  Experiments using ES-
derived neural progenitors have shown that these cells, too, experience 
developmental plasticity that is affected by their age, in that cells gave rise to a 
variety of cell types, including Cajal-Retzius, upper and lower layer pyramidal 
neurons.  Aligning the birthdates of these cell populations with their marker 
expression patterns revealed that progenitors gave rise to different regional 
neuronal subtypes in waves of neurogenesis reminiscent of in vivo patterns 
(Gaspard and Vanderhaeghen, 2010).  Additionally, ES-derived progenitors 
cultured for various amounts of time then grafted into recipient mice showed 
propensity to develop into distinct regional cortical neuronal subtypes, with 
axonal projections corresponding to their neurogenic layer-specific potential 
acquired in vitro (Gaspard and Vanderhaeghen, 2010).  In a stunning finding, ES-
derived cells grown in culture can form rudimentary structures resembling 
normal, in vivo, brain development (Gaspard and Vanderhaeghen, 2010; Eiraku 
et al. 2008).  While the ES-derived progenitors give rise to neurons displaying 
phenotypes of various cell layers, they are unable to form the complete, 
organized structure of the neocortex (Gaspard and Vanderhaeghen, 2010), the 
most recently evolved brain structure.  This could indicate that the ES-derived 
cells display a more primitive phenotype, or that these cells are simply missing 
some of the signals from local brain stroma.  Regardless, the finding that cells 
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can organize into a brain-reminiscent structure, completely removed from the 
body and thus completely dependent on cell population-intrinsic events, is 
remarkable. 
These results, taken all together, indicate that hES culture is an ideal 
system for studying transcriptome dynamics in neural differentiation.  They also 
underscore another important point.  Spemann and Mangold could not have 
known at the time how the molecules secreted by the organizer and ectoderm 
effected such major changes in the tissue.  Subsequent work has revealed that 
these signaling pathways work, via binding of ligands to specific receptors, by 
activating cascades that eventually lead to transcriptional activation and 
repression.  Binding of BMP to its receptor, for instance, induces phosphorylation 
(and thus activation) of SMAD protein effectors (Shi and Massague, 2003), which 
are themselves transcriptional modifiers.  The SMADs activate and repress a set 
of downstream genes that, in the hES cell context, push cells to differentiate into 
trophoectoderm (an extra-embryonic tissue that gives rise to the placenta) (Xu et 
al. 2002).  But these signalling pathways (and the genes they activate) work 
through an incredibly complex network of factors that exert effects on many 
different layers, including chromosome structure, gene accessibility, and many 
forms of downstream control to coordinate the balancing act of stem cell renewal 
and differentiation into multiple tissue types.  It is truly astounding that this 
meshwork of regulation, involving so many intermingling parts, works so well, so 
consistently, in the process of human development. 
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Coordinated Layers of Gene Regulation 
The process of differentiation is governed, at its foundation, by changing 
gene expression.  Gene regulation, in all cells, takes place on a number of levels 
(Figure 1.4). Chromatin structure, including nucleic acid secondary structures 
and modifications to the DNA and DNA-binding histones, plays a major role in 
the accessibility of genomic regions to a cell’s transcriptional machinery.  
Histones can be modified in many ways, including methylation, acetylation, 
phosphorylation and SUMOylation.  Previous studies have shown that Polycomb 
group (PcG) protein complexes PRC1 and PRC2, active in embryonic stem cells, 
help repress expression of lineage development genes by recruiting 
transcriptional repressors to chromatin (Hirabayashi & Gotoh, 2010). There is a 
growing body of evidence suggesting that the particular epigenetic profiles of 
individual genes, dependent upon the particular combinations DNA and histone 
“marks,” places them in active, silenced, or “poised” states of expression. The 
presence of tri-methylation at the histone H3 tail’s lysine(K)-4 (the 4th amino acid 
on the tail) (H3K4me3) is generally indicative of an actively expressed gene – 
studies have shown that elements of the transcriptional machinery bind directly to 
H3K4me3, enhancing transcriptional elongation (Vermuelen et al. 2007). 
H3K27me3, on the other hand, is a repressive mark on transcription.  Methylation 
is catalyzed by EZH2, part of the PRC2 complex (Kuzmichev et al. 2002).  The 
exact function of this mark is not entirely understood, but it has been shown to 
recruit PRC1 for attachment of ubiquitin to another histone tail lysine (de Napoles 
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Figure 1.4.  Model of the meshwork of gene regulatory layers.  Regulation of 
activity and function occurs across all layers, and there is abundant evidence of 
crosstalk across all layers.  For instance, dynamic chromatin structure allows 
transcriptional machinery to access different genes’ promoters at different times.  
Alternative splicing can affect chromatin remodelers’ sequencing binding 
specificity.  Post-translational phosphorylation can activate or de-activate splicing 
factors.  Adapted from Blencowe, 2006. 
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et al. 2004).  Ubiquitination serves to stall elongation by RNA polymerase II 
(Stock et al. 2007).  There are many cases in which both of these epigenetic tags 
are present, meaning that subtle changes in the expression or regulation of the 
proteins responsible for depositing, maintaining, or removing these marks will 
lead to rapid, major changes in gene expression.  Within stem cells, these 
bivalent histone modifications decorate a number of lineage-specific patterning 
and specification genes, silencing them in pluripotency but leaving them primed 
for expression as cells begin to differentiate (Hirabayashi and Gotoh, 2010).  
Further modifications, including methylation or acetylation at other lysines, along 
with phosphorylation of serine residues, affect “fine tuning” of the transcriptional 
landscape (Vermuelen et al. 2010).  Histone remodeling has effects beyond the 
direct effects on transcription; these marks serve as signals for further 
nucleosome-remodeling events that can put cells in more permanent states of 
(in)activity, including DNA methylation. 
The next “layer” of regulation lies in the transcriptional apparatus itself, 
involving polymerase and transcription factor proteins that change the affinity and 
activity levels of other transcriptional players, and is a major focus of many 
research labs.  One of the most profound discoveries in stem cell biology was the 
understanding of the “master transcriptional regulatory apparatus,” the 
transcription factors OCT4, SOX2 and NANOG.  OCT4 and SOX2 can form a 
complex and directly bind to regulatory elements in promoters to activate and 
maintain transcription of “stemness” genes (including their own) and repress 
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lineage-specific genes, like Pax6 (ectoderm) and Atbf1 (endoderm) (Boyer et al. 
2005) (Figure 1.5).   
Many genes bound by OCT4 and SOX2 are co-occupied by NANOG.  
Further, the transcriptional network’s importance is clearly demonstrated by the 
fact that the two labs that simultaneously induced mature cell types to “de-
differentiate” into iPSC used 2 common factors (out of 4 total) to do so: the stem 
cell transcription factors Oct4 and Sox2 (Takahashi et al. 2007; Yu et al. 2007). 
There are a great many groups studying stem cell-specific transcription factors, 
and the known network of interacting transcription factors necessary for these 
processes continues to grow at a rapid pace.  Most studies of transcriptional 
regulation in the context of neural differentiation have focused on characterizing 
single genes and how their expression or silencing affects differentiation 
potential.  These experiments can have simple beginnings, yet are extremely 
elegant and powerful in their implications.  For instance, the transcription factor 
Sox1 is known to be one of the earliest expressed markers for neural lineage 
cells in mice.  Activation of expression of another transcription factor, Pax6, 
follows a few days later as the cells become more organized into early neural 
structures.  A group of researchers, however, noticed that the pattern of 
expression of these two markers is reversed in humans.  Indeed, through careful 
manipulation, they found that knockdown of Pax6 in hESC blocked 
neuroepithelial specification, both in teratoma (in vivo) and in vitro neural 
differentiation assays (Zhang et al. 2010).  The gene’s overexpression drove 
cells to rapidly differentiate into the neural lineage (Figure 1.6). Furthermore, the  
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Figure 1.5.  Schematic representing the cooperative actions of the core hES 
transcription factors NANOG, OCT4 and SOX2.  These factors activate 
expression of pluripotency-maintenance genes while repressing lineage-specific 
and general differentiation factors.  Excerpted from Boyer et al. 2005. 
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Figure 1.6.  Effects of Pax6 overexpression and knockdown in ES cells on neural 
differentiation capability.  Overexpression drives cells into neural lineage, while 
knockdown blocks formation of neuroepithelium.  Schematic of findings in Zhang 
et al. 2010. 
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effects of Pax6 were not due to the gene’s necessity in any specific neural 
induction assay – an alternate method, involving dual SMAD (a group of BMP 
pathway effector molecules) inhibition, used to drive hESC into the neural lineage 
was also blocked. The chromatin-binding assay ChIP was used to determine that 
PAX6 directly binds to promoter regions of “master” stem cell transcription 
factors, Oct4 and Nanog, as well as neural genes like Six3 and Meis2 (Zhang et 
al. 2010).   
There is obviously a great amount of coordination between the players 
acting at any “stratum” of regulation, but the different layers also show a 
significant degree of crosstalk.  For instance, there is some evidence that OCT4 
can recruit PcG complexes, presumably to methylate H3K27 and silence lineage-
specific genes (Christophersen and Helin, 2010).  Other studies have 
demonstrated that epigenetic marks can affect splicing patterns, discussed 
below. 
 Post-transcriptional modifications are also important in gene regulation.  
This term covers a range of cellular activities, including small RNA-induced gene 
silencing, RNA editing, and alternative splicing & polyadenylation.  MicroRNAs 
(miRNA) are an important class of regulatory RNA elements that bind to mRNA 
molecules in a sequence-specific manner to induce cleavage or translational 
repression of the target mRNA.  These molecules were first discovered in a 
developmental screen in C. elegans (Lee et al. 1993), but subsequent work has 
demonstrated the important role they play in higher organisms including mice 
and humans.  There are over 1400 human miRNAs (Kozomara et al. 2011), and 
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a subset is preferentially expressed in ES cells (Houbaviy et al. 2004).  Mice 
deficient in the miRNA processing machinery fail to develop (Bernstein et al. 
2003), while mES cells lacking elements of the miRNA biogenesis pathway show 
defects in proliferation and differentiation (Wang et al. 2007).  Recent work has 
helped explain these findings, while placing them in the context of the 
overarching regulatory framework.  As it turns out, the master stem cell 
regulators OCT4, SOX2, and NANOG (along with TCF3) bind cooperatively to 
promoter regions to activate or repress transcription of miRNA genes (Marson et 
al. 2008).  As described above, these transcription factors perform a similar 
function at promoters of protein-coding genes (Boyer et al. 2005), and just as in 
that case, it appears the stem cell master regulators bind ~20% of all miRNA 
genes.  Many of the OCT4-activated miRNAs work to reinforce expression of 
protein-coding genes; for example, the master TFs bind and activate expression 
of the DNA methyltransferases Dnmt3a/b (Marson et al. 2008).  They also 
activate expression of a cluster of ES-specific miRNAs, the miR-290-295 cluster, 
which themselves, indirectly, maintain Dnmt gene expression.  These miRNAs 
may exert their effect via repression of RBL2 in a dis-inhibitory mechanism 
(Marson et al. 2008) (Figure 1.7).  Interestingly, this same miRNA family 
represses expression of LEFTY1/2.  These BMP-family signalling molecules are 
crucial for left-right axis determination in developing embryos and are highly 
conserved (the zebrafish homolog of the mammalian miR-290-295 family 
represses LEFTY1/2 [Choi et al. 2007]).  The master TFs also directly bind and 
serve as activators for expression of Lefty1/2.  This mechanism – in which the  
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Figure 1.7.  Coordinated, “coherent” feed-forward regulation by master hES 
transcription factors on Dnmt3.  OCT4/SOX2/NANOG/TCF3 directly bind Dnmt3 
promoters to activate transcription.  These TF’s also activate transcription of miR-
290-295 cluster that, through repression of the normally inhibitory protein RBL2, 
augments Dnmt expression.  Excerpted from Marson et al. 2008. 
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regulator has both positive and negative effects on target expression – has been 
described as “incoherent feed-forward” regulation (Alon, 2007), and could be a 
way to fine-tune expression of proteins (Figure 1.8).  In the case of signaling 
molecules like LEFTY1/2, small perturbations in expression can have drastic 
effects as these molecules exert differential effects on cells and tissues based on 
their gradients of expression.  Over 25% of miR-290-295 targets are co-bound by 
OCT4/SOX2/NANOG/TCF3, indicating a significant role for miRNAs in 
modulating transcription factor effects in the stem cell milieu (Marson et al. 2008).  
Further, elements of the same gene-silencing apparatus employed in protein-
coding gene silencing are co-opted in the modulation of miRNA expression – 
many of the TF-bound miRNAs that were silenced in ES cells and expressed in 
differentiated cells also showed promoter-region binding of SUZ12 (a PRC2 
Polycomb complex histone methyltransferase) and presence of the silencing 
H3K27me3 mark described above (Marson et al. 2008). These examples help to 
reinforce the model of an interconnected meshwork of regulatory mechanisms, 
working in concert to ensure appropriate expression of ES maintenance- and 
differentiation-promoting players. Additionally, without our growing understanding 
of epigenetics, aspects of the above experiment would have been impossible – 
the miRNA gene promoters were identified through ChIP-seq, using antibodies 
against H3K27me3 (Marson et al. 2008). 
Finally, there are translational and post-translational mechanisms of 
regulation, including secondary structure effects on ribosomal translation 
efficiency and protein phosphorylation by various kinase enzymes.  As noted  
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Figure 1.8.  “Incoherent” feed-forward regulation of Lefty1/2 by master hES 
transcription factors.  The TF’s activate expression of Lefty1/2, but also drive 
expression of miR-290-295 cluster.  These miRNAs repress LEFTY1/2 protein 
expression.  The relative balance of these two actions could be a method to fine 
tune expression of this important signaling molecule. 
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above, these processes are coordinated, and changes in one level can augment 
or mitigate upstream and downstream effects.  That is, expression of alternatively 
processed RNA products can affect the function, localization and/or regulation of 
upstream (e.g. chromatin-remodeling) and downstream (e.g. protein kinase) 
elements, and vice versa. 
As described above, great progress has been achieved in identifying 
signaling pathways involved in neural differentiation.  Spemann and Mangold’s 
experiments, and those of the following several decades, helped elucidate the 
extremely complex (and apparently conserved) roles of BMP, FGF and WNT 
signaling in neural development from flies to frogs to mice to humans.  Elegant 
and thoughtful experiments, like those described above, have revealed the 
additional input of Notch, Hedgehog and retinoic acid signaling (Gaspard and 
Vanderhaeghen, 2010) on downstream aspects of neuronal maturation.  
Likewise, the role of small RNA regulation on these processes is the main 
avenue of research for many laboratories.  The role of alternative splicing in 
developmental processes, however, has remained largely elusive.  Importantly, 
as in the Pax6 example above, many of the transcription factors being studied 
are alternatively spliced (Cauffman et al. 2006), as are a number of the important 
signaling molecules and their receptors (e.g. FGF receptors) (Orr-Urtreger et al. 
1993).  
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Alternative Splicing  
Importance and Preponderance 
Alternative splicing (AS) describes the process in which different 
combinations of precursor messenger RNA (pre-mRNA) exons (and, sometimes, 
introns) are joined together to form distinct mature mRNAs.  AS is an extremely 
important process, conserved across all eukaryotes, as it dramatically increases 
protein diversity without a concomitant increase in genetic material – humans, 
despite having a much larger genome, only have about 4 times as many 
identified genes as budding yeast, and roughly the same number as the 
nematode worm C. elegans.  Almost all human genes with multiple exons 
undergo AS, and a single alternatively spliced gene can generate anywhere from 
two to several thousand mRNA isoforms (Nilsen and Graveley, 2010).  Splicing 
events most commonly take one of three forms: alternative 5’ or 3’ splice sites, 
cassette exons, and retained introns (Figure 1.9).   
The combination of AS, RNA editing, and the post-translational 
modifications briefly described above allow for a massive number of functionally 
distinct proteins (Nilsen and Graveley, 2010).  It is important to tightly regulate 
splice site selection, intron removal and exon ligation, as aberrant splicing could 
lead to non-functional or deleterious protein production, or prevent mRNA 
translation entirely.  The spliceosome, a complex made up of hundreds of 
proteins and five associated RNA molecules, interacts with cis-acting regulatory 
sequence elements and trans-acting splicing factors (including SR [serine-
arginine] proteins, heterologous nuclear ribonucleoproteins [hnRNPs] and other  
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Figure 1.9.  Schematic representing the most common types of alternative 
splicing events.  (L) Alternative 5’ (top) and 3’ (bottom) splice sites.  (R) Cassette 
exon (top) and intron retention (bottom), where the central exon or intron can be 
either included or excluded from final mRNA product.  Sequence-based (cis-
acting) factors and dynamic expression of splicing proteins (trans-acting) 
combine to determine contextual splicing patterns. 
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RNA-binding proteins [RBPs]); the interplay between these elements defines the 
“splicing code,” the rules that will govern the observed splicing patterns (Barash 
et al. 2010).  Estimates of the proportion of all human genes known to undergo 
alternative splicing (AS) have risen constantly as methods and technology for 
detection of alternative transcripts have improved.  It is now estimated that at 
least 94% of all human genes undergo some form of AS, producing mRNA 
transcripts that differ in their inclusion and exclusion of exons and introns (Pan et 
al. 2008; Wang et al. 2008), and studies have shown that at least 15% of all point 
mutations disrupt normal splicing, demonstrating the importance of AS in human 
diseases (Licatalosi & Darnell, 2010).  Alternative transcripts often result in 
proteins with altered structure, localization and/or function, and AS can also be 
used to regulate mRNA levels through nonsense-mediated decay (NMD) of 
isoforms containing premature termination codons (PTC); the fact that some 
exons involved in the generation of PTCs are associated with ultraconserved 
elements indicates that this may be an ancient, evolutionarily-conserved 
regulatory mechanism (Lareau et al. 2007).  Many genes show alternative 
isoforms with 3’ untranslated region (UTR) differences affecting miRNA 
regulation (Salomonis et al. 2009), which has important implications in cell 
proliferation at different developmental stages (Sandberg et al. 2008).  It has 
been proposed that AS is a primary driving force behind the incredible 
phenotypic complexity seen in mammals (Wang et al. 2008).   
AS patterns can be dictated by developmental (e.g. sex-specific) (Sanchez, 
2008) or differentiation (Makeyev et al. 2007) pathways.  Sex determination in 
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Drosophila melanogaster starts with the sex-specific splicing pattern of Sex-lethal 
(Sxl); the SXL protein itself is a splicing regulator that controls splicing of 
downstream genes, ensuring the appropriate, sex-specific expression of isoforms 
(Figure 1.10).  Surprisingly, while Sxl has orthologues in many other species, the 
orthologous genes in non-drosophilids, including Anopheles mosquitos, the 
housefly M. domestica, and even other Drosophila spp., are not expressed in a 
sex-specific manner.  This indicates that the sex-determination effects of Sxl 
splicing arose during the development of the Drosophila lineage, co-opting a 
gene previously reserved for other, unknown functions (Sanchez, 2008). 
 
Feedback on Regulatory Layers 
Alternative RNA processing can also have a dramatic impact on the other 
layers of the regulatory network.  One important epigenetic modification, 
mentioned above, is DNA methylation.  The DNA methyltransferase (DNMT) 
enzymes are responsible for establishing the patterns of DNA methylation in hES 
cells, and DNMT3B is known to be largely responsible for this process.  The 
Dnmt3b gene is, however, highly alternatively spliced, giving rise to at least 40 
isoforms (Nelles and Yeo, 2010).   The DNMT3B3 protein isoform lacks the 
catalytic segment required for methylation, as does the more recently discovered 
DNMT3B3D5 variant.  These isoforms are both highly expressed in hES cells 
and brain tissue, but are down regulated during differentiation. DNMT3B3D5 
shows higher DNA-binding affinity than other isoforms (Gopalakrishnan et al. 
2009); it has been proposed that this isoform may function as a competitive  
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Figure 1.10.  Sex-specific splicing patterns of three major Drosophila sex-
determination genes.  Precursor mRNA (pre-mRNA) molecules are in the middle 
panel, while the female- and male-specific mRNA products are on the left and 
right, respectively.  Early expression of the SXL protein in females drives female-
specific splicing patterns of Sxl and Tra, a downstream splicing regulator that 
ensures appropriate sex-specific splicing of Dsx.  From Gilbert, 2000. 
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“sponge,” blocking the action of catalytically active DNMT3B isoforms and thus 
preventing hypermethylation of target genes (Nelles and Yeo, 2010).  
The transcription factor OCT4 (encoded by Pou5f1), described briefly 
above, is a central player in pluripotency maintenance.  OCT4 has been used as 
a specific marker for ES cells; its expression was reported as restricted to 
embryonic stem cells and it appears to be indispensible for reprogramming of 
somatic cells into iPSC.  Some reports, however, indicated that OCT4 was also 
expressed in some somatic tissues (Zangrossi et al. 2007).  Further investigation 
revealed that Pou5f1 is alternatively spliced, giving rise to 3 annotated, 
differentially regulated, isoforms.  Pou5f1a is expressed only in stem cells (and 
stem cell-like cancerous cells) and can initiate expression at OCT4 initiation 
sites.  Pou5f1b, expressed in a wide range of somatic tissues, cannot initiate 
expression at OCT4 sites (Lee et al. 2006).  To complicate the picture further, the 
third isoform, known as Pou5f1b1, shows a similar expression pattern to Oct4a, 
although its function is not entirely understood.  It is highly likely that these 
isoforms serve distinct functions, underlining the importance of AS as a 
regulatory mechanism within the Oct4 setting (Nelles and Yeo, 2010).  Also, as 
mentioned above, alternative use of 3’ exons, as well as alternative 
polyadenylation, can dramatically affect the dynamics of miRNA regulation of 
mRNAs (Salomonis et al. 2009, Sandberg et al. 2008). 
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Tissue-specific AS and its Role in Neuronal Differentiation 
 AS provides an attractive and logical model for tissue-specific modulation 
of mRNA populations, as localized, altered expression patterns of auxiliary 
splicing factors could tweak the splicing code.  Many experiments have 
demonstrated the widespread nature of tissue-specific alternative splicing.  The 
process of AS occurs in all human tissues but studies have consistently 
demonstrated that brain, muscle and testis tissue samples show a higher degree 
of AS among expressed genes than other tissues; brain samples show the 
greatest isoform diversity (Wang et al. 2008; Pan et al. 2008; Yeo et al. 2004).  
Studies have shown that AS of neuronal receptors can alter clustering, ligand 
affinity, and ion conductance (Grabowski and Black, 2001).  Alternative splicing 
patterns can change in response to activation of signaling pathways (Lynch, 
2005) or even cellular depolarization events in individual neurons (Xie and Black, 
2001).  There are a number of neuronal-specific splicing factors, including Nova 
(Licatalosi and Darnell, 2010) and neural-specific polypyrimidine tract binding 
protein (nPTB) (Rahman et al. 2002) that play important roles in regulating 
expression of large sets of neuronal-specific isoforms.  
Furthermore, a growing body of evidence validates AS as a crucial 
mechanism in stem cell self-renewal and neural differentiation. OCT2 (encoded 
by Pou2f2), like OCT4, is another member of the POU family of transcription 
factors, though less well characterized than OCT4.  It is highly expressed in 
mice, both in the developing CNS and in the adult brain.  The Pou2f2 gene, too, 
is alternatively expressed, and the effects are dramatic.  Overexpression of 
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OCT2.2 protein is sufficient to induce neural differentiation of mouse ES cells, 
while overexpression of another variant, OCT2.4, is sufficient to block this 
differentiation pathway, even in the presence of other known neural inducers 
(Theodorou et al. 2009).  The work of Zhang et al., described above, uncovered 
Pax6’s role as a determinant of neural specification. Complicating the picture, 
though, is the fact that Pax6 is alternatively spliced.  One protein isoform, 
PAX6A, binds both pluripotency- and neural differentiation-inducing gene 
promoters, while PAX6B only binds the pluripotency gene promoters.  This is 
consistent with the observation that specific Pax6a isoform overexpression drove 
cells into the neural lineage, while overexpression of only the Pax6b isoform 
(distinguished by the inclusion of a cassette exon encoding 14 amino acids that 
alters the sequence specificity of the DNA-binding domain) also directed cells out 
of the hES lineage, but into non-neural cell types (Zhang et al. 2010) (Figure 
1.11). 
 
Exploiting Next-Gen Sequencing to Survey Alternative Splicing 
One of the many advantages associated with deep sequencing, 
mentioned above, is that one is not limited to detecting an expected set of events 
(as one would be with a microarray or other hybridization-based technology).  A 
proportion of sequence reads that do not map perfectly to the reference genome 
can be mapped to exon-exon junctions.  Publicly available software packages 
like TopHat (Trapnell et al. 2009) can use either existing annotations of exon- 
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Figure 1.11.  Distinct effects of two alternative splicing variants of Pax6 on hES 
differentiation.  Overexpression of Pax6a drives cells to rapidly differentiate into 
the neural lineage, while overexpression of Pax6b drives differentiation into non-
neural cell types.  Schematic of findings from Zhang et al. 2010. 
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exon junctions, or construct transcript models de novo, depending on whether 
one wants to attempt to analyze novel splicing events. 
 Recently, the Burge group used NGS to study patterns of alternative 
splicing across human tissues.  They showed that, among multi-exon genes 
(~94% of all human genes), the process of AS is essentially universal, with 92% 
of these showing a minor isoform frequency of at least 15% (Wang et al. 2008).  
NGS also allows for powerful analyses regarding individual genes and splicing 
events; using combinations of reads that hit individual exons or cross exon-exon 
junctions, the Burge group were able to estimate “inclusion ratios” for cassette 
exons (and other types of AS events) in the different tissues.  They found that, on 
average, 60% of all AS events (52%-80%, depending on splice event type) are 
regulated in a tissue-specific manner, lending credence to the idea that 
alternative splicing is a major contributor to phenotypic complexity in mammals.  
Their findings are also informative to human disease models; as an example, 
mitochondrial phosphate transporter SLC25A3 transcripts can only include one of 
the mutually exclusive cassette exons 3A and 3B.  Sequence reads from skeletal 
muscle and heart samples showed much greater coverage of exon 3A than all 
other tissues studied, consistent with the pattern of symptoms seen in patients 
with exon 3A mutations (Figure 1.12).   
Finally, they examined tandem 3’ UTR extensions demonstrating patterns 
of tissue regulation – by mining the regions upstream of each polyadenylation 
site for enriched heptanucleotides, Burge’s group discovered not only expected 
miRNA binding sites, but also binding motifs for FOX1/2 and other canonical  
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Figure 1.12.  Splicing analysis of Slc25A3 gene by mRNA-seq, demonstrating 
tissue-specific patterns of mutually exclusive exon usage.  Excerpted from Wang 
et al. 2008. 
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splicing factors, possibly indicating a novel role for these proteins in mRNA 
polyadenylation, localization or translation (Wang et al. 2008) – possibly to help 
ensure the appropriate combination of transcript and 3’ UTR in tissue-specific 
isoforms. 
 Methods involving NGS are helping to unveil the complicated manner in 
which RNA-RNA-binding protein (RNABP) interactions can modify tissue- and 
developmental stage-specific expression of particular mRNA isoforms.  RNA-
RNABP complexes can be crosslinked using UV irradiation; after subsequent 
protein digestion, ligation of linkers and cDNA production, stretches formerly 
bound by specific RNABPs can be sequenced.  This technique, called high 
throughput sequencing-crosslinked immunoprecipitation (HITS-CLIP), has 
already been applied to a number of RNABPs, including NOVA (Licatalosi et al. 
2008) and FOX1/2 (Yeo et al. 2009); these studies, along with other methods, 
provide strong evidence that the location of RNA-RNABP interactions in a pre-
mRNA transcript dictate resulting splice patterns (Licatalosi and Darnell, 2010) 
(Figure 1.13).  HITS-CLIP also revealed that NOVA directly regulates a 
coordinated group of mRNAs whose proteins function in the synapse (Licatalosi 
et al. 2008).  With enough information about cis-acting splicing regulatory 
sequences, expression levels of trans-acting splicing factors and their target 
binding sites, we should be able to predict the relative abundance of individual 
mRNA transcripts present in any given cell or tissue.  Indeed, the Blencowe and 
Frey groups have already produced a “splicing code” that, given genomic 
information about a given  
 59 
Figure 1.13.  HITS-CLIP analysis of NOVA tag locational effect on splicing 
pattern.  Binding of NOVA at the 5’ end of alternative exons predominantly leads 
to exon exclusion, while enriched binding at the exon’s 3’ end encourages exon 
inclusion in the final mRNA product.  Adapted from Licatalosi et al. 2008. 
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mouse exon and its upstream & downstream flanking introns and exons, will 
predict whether the exon is alternatively spliced and, if so, whether its inclusion 
will increase or decrease in any given tissue, relative to other tissues (Barash et 
al. 2010).  They used their code to analyze splicing patterns in previously un-
investigated exons and were able to validate most of their findings by microarray 
and/or RT-PCR.  They also discovered a potentially important gene regulatory 
mechanism in which alternative exons introducing PTC are included in mature 
cells but excluded in embryonic tissues and stem cells, with important 
implications on proliferation.  The fact that the splicing code is able to 
successfully predict splicing patterns is astonishing, especially given that it does 
not incorporate expression levels of the RNABPs involved or small RNAs that 
might selectively degrade individual isoforms.  It stands to reason that the more 
data we can add (including expression levels of coding and non-coding genes 
from mRNA and miRNA-seq, respectively) to this model, the more informative 
and robust its predictions will be.   
 The Snyder group recently characterized the transcriptome during early 
neural differentiation of human H1 embryonic stem cells.  They discovered 
thousands of unannotated transcriptionally active regions (TARs) and mRNA 
isoforms.  They also describe a phenomenon they call “isoform specialization,” 
where the differentiating early neural lineage cells show lower splicing isoform 
diversity than hES cells (Wu et al. 2009).  This finding seems to dispute the bulk 
of findings in previous literature in the field – that the brain and neuronal cells 
show the highest amount of alternative splicing of all tissues.  The Snyder group, 
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however, looked at early neural specification, and it could be that splicing 
diversity decreases early in the process of neural patterning, then subsequently 
increases as cells become more terminally differentiated. 
 
The Future of the Field 
 There are certainly limitations to sequencing-based expression analysis. 
The most vexing issue of mRNA analysis using short-read technology is the fact 
that reads, at current Illumina sequencing length, only cross one or two exon 
junctions at most.  As a result, the output lacks information on full-length 
transcripts.  Even using Cufflinks, with the advantage of elegant mathematical 
algorithms using probability-based transcript mapping, there is the drawback of 
relying on existing annotations, which could be based on a single cloned cDNA 
from any given tissue at any given time.  The use of random hexamers in the RT 
step of library preparation introduces bias (Hansen et al. 2010).  The PCR step of 
library preparation carries biases as well – smaller pieces of DNA amplify better 
than larger pieces, AT- and GC-rich regions are more difficult to amplify, the 
linear nature of amplification is lost at high cycle numbers (in essence, a 
saturation effect), and low-abundance transcripts may not amplify well, or at all.  
Reads from highly repetitive regions of the genome cannot be reliably mapped.  
Region-specific biases, resulting in uneven coverage across exons and genes, 
are also prevalent (Mortazavi et al. 2008) (Figure 1.14).  Until recently, most 
RNA-seq protocols yielded reads that lack strand information, which means that 
areas with overlapping genes on opposite strands are difficult or  
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Figure 1.14.  Example of uneven sequence coverage seen across Gapdh exons 
and genes from mRNA-seq data.  Sequence bias is generated by a number of 
factors, including GC content and differential binding affinity of random hexamer 
RT primers.  Importantly, similar bias is seen across all samples, meaning that 
longitudinal gene analysis across samples is still valid. 
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impossible to interpret.  Strand-specific library prepration methods now exist, but 
rely on more manipulation of the highly-labile RNA (Ozsolak and Milos, 2011). 
One area of ambiguity within mRNA-seq datasets involves correlating read 
quantities to cellular context; sequencing results are digital counts of reads, but 
the translation of readcounts to RNA transcript abundance is still not clear.  
Additionally, while there are a number of software suites available for dataset 
analysis, they are not trivial to operate; without a computer science background, 
many biologists find themselves bogged down in analysis.  Custom-designed 
scripts, which may be the ideal method for mining particular data from these 
massive datasets, are impossible to create without a significant amount of 
training. 
The current generation of technology continues to advance, with total 
possible readcounts increasing due to improvements in flowcell design, camera 
resolution, and library preparation technique improvements.  Despite these 
improvements, however, it seems impossible that NGS will achieve the “$1,000 
genome” – the ability to sequence an entire human genome for $1,000 or less, a 
challenge proposed by the NIH to be solved by the year 2014.  The third (“next-
next-gen”) generation of sequencing is likely to be based on amplification-free 
single molecule sequencing, where it will be possible to massively sequence full-
length mRNAs in parallel, possibly using nanopore or other technology (Blow, 
2008).  As sequencing continues to expand in popularity, companies will 
presumably work to produce more user-friendly tools for data analysis. 
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It is extremely important that mRNA sequencing can only scratch the 
surface of the puzzle of gene regulation in development.  This approach must be 
combined with others detailed above, including ChIP-seq (to examine chromatin 
regulation), small RNA sequencing, and of course proteomic studies, as these 
layers all contribute to the global regulatory network governing the complex 
processes involved in development. 
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CHAPTER 2 
Transcriptome Analysis of Human Embryonic Stem and Neural 
Lineage Cells 
 
Abstract 
Human embryonic stem cells (hESC) have a great deal of potential for use 
in regenerative medicine.  They also represent an ideal system for studying 
developmental processes and pathways.  We used a well-established protocol to 
efficiently drive hESC down the neural lineage into spinal motor neurons (MN). 
 We extracted RNA samples from 6 important stages of development and 
performed RNA-seq to analyze dynamic transcriptome changes during the 
maturation of these cells.  We detected hundreds of genes, and thousands of 
transcripts, demonstrating significant changes in expression across each 
developmental transition.  Pathway analysis revealed enrichments of key 
signaling pathways and processes involved in neural patterning and neuronal 
maturation.  Detailed analysis of differential splicing revealed coordinated 
regulation by known and unknown splicing factor proteins.  Further, we 
successfully validated a number of observed gene and isoform level changes. 
 Our mRNA-level analysis, described here, can be combined with emerging 
knowledge of epigenetics and proteomics to facilitate our deeper understanding 
of the complex processes governing the development of the human central 
nervous system (CNS). 
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Introduction 
Neuronal differentiation is a highly complex process in which thousands of 
cellular subtypes are specified from pools of stem and progenitor cells that 
differentiate and migrate in response to signals derived from underlying 
mesoderm and nearby ectoderm.  The expression of neural differentiation (and 
the silencing of “stemness”) factors must take place in a tightly controlled 
manner, both spatially and temporally.  Previous work has demonstrated, 
perhaps not surprisingly, that there are many layers of regulation governing this 
process, including at the epigenetic, transcriptional, post-transcriptional and post-
translational levels (Yeo et al. 2007).  While much progress has been made in 
elucidating the roles of chromatin remodeling, transcription factors and miRNA-
based regulation, the contributions of alternative RNA splicing (AS) have 
remained mostly elusive.  Indeed, mounting evidence indicates that AS plays an 
important part in development and differentiation.  Alternative isoforms of Oct4 
(Pou5f1) and Oct2 (Pou2f2) have been shown to have reciprocal effects on stem 
cells’ neural differentiation capabilities (Nelles and Yeo, 2010).  The neurexin 
(Nrxn) family of cell adhesion molecules consists of three Nrxn genes that 
undergo complex patterns of AS to generate hundreds or thousands of possible 
final protein complexes; individual isoform selection is thought to play a crucial 
role in mediating appropriate synapse formation (Grabowski and Black, 2001). 
 Other studies have detected dramatic differences in isoform expression between 
stem and differentiated cells of various lineages (Yeo et al. 2007, Salomonis et 
al. 2009).  Recent work has demonstrated that AS is a near-universal process; 
 69 
nearly every multi-exon gene in the human genome has been shown to undergo 
AS in some form (Wang et al. 2008), and studies have consistently demonstrated 
that the brain shows the highest proportion of genes undergoing AS, another 
indication of the importance of this mechanism in neural differentiation. 
Much of what is known about central nervous system (CNS) formation 
comes from work with animal models.  Transgenic animals, using GFP or stage-
specific-inducible “fate-mapping” experiments to map expression patterns, have 
allowed researchers to temporally track the activation and silencing of individual 
transcription factors, signaling molecules, etc.  Moral and ethical concerns, 
however, preclude these types of experiments in humans, and brain biopsies are 
far too dangerous and invasive to be performed routinely on developing fetuses. 
 Therefore, a suitable in vitro system is necessary.  Human embryonic stem cells 
(hESC) are derived from the inner cell mass of blastocyst-stage embryos.  They 
can self-renew indefinitely in culture and have the ability to differentiate into cells 
from all three germ layers (Thomson et al. 1998).  Furthermore, differentiated 
cells can be “re-programmed” back into an hESC-like state (Yu et al. 2007); 
these cells are induced pluripotent stem cells (iPSC) and appear highly similar to 
hESC in their global epigenetics and gene expression profiles (Bock et al. 2011). 
 hESC and iPSC have the potential to transform regenerative medicine – for 
example, whole livers could be grown in a lab for transplantation in cases of liver 
failure, or progenitor cells could be injected into the brain of a patient with 
Parkinson’s disease, where they could differentiate into the dopaminergic 
neurons whose death leads to the neurodegeneration seen in these patients. 
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 Although these types of interventions are still barely past the theoretical stage, 
hESC provide a great model system for studying human development; apart from 
animal models, hESC culture is the best way to attempt to recapitulate the 
development of the human CNS. 
Most previous attempts at characterizing transcriptome expression have 
employed microarray platforms.  Arrays can be powerful tools for studying 
expression, but they carry inherent drawbacks, including space limitations, cross-
hybridization, and limited dynamic range; additionally, microarray results can vary 
dramatically from lab-to-lab or run-to-run (Wold and Myers, 2008).  Most 
importantly, microarray interrogation relies entirely on hybridization to pre-
synthesized probes; therefore, they will identify only molecules they have been 
designed to identify.  Detection of novel genes or isoforms, using a microarray, is 
nearly impossible.  Recently, next-generation sequencers have made possible 
entire transcriptome analysis at single-nucleotide resolution.  Output sequence 
reads can be mapped unambiguously to a reference genome, yielding “digital” 
expression data.  This lack of ambiguity is extremely important in the context of 
splicing analysis.  Raw sequence reads can be aligned not only to uninterrupted 
reference genomic sequence, but also to a “splice junction index,” an additional 
database of sequence comprised of exon-exon junctional sequences.   
  
Experimental Procedures 
Cell Culture and Differentiation 
H9 hES cells were obtained from the UConn Stem Cell Core Facility and 
maintained under standard conditions in co-culture with mouse embryonic 
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fibroblasts (MEF).  Directed differentiation into spinal motor neurons was 
performed as previously described (Li et al. 2005, Li et al. 2008).  Briefly, H9 cells 
were transferred to low-attachment flasks and cultured for four days with ES cell 
medium (DMEM/F12, knockout serum replacer, NEAA, 1 mM L-glutamine, 0.1 
mM 2-mercaptoethanol) to form ES aggregates.  Aggregates were then re-
suspended in flasks in neural induction medium (DMEM/F12, N2 supplement, 
NEAA, heparin) and cultured for an additional 2-4 days.  At this point, ES cell 
aggregates were attached to laminin-coated flasks (20 ug/mL).  After attachment, 
cells were cultured with neural induction medium (as above) until early neural 
rosettes (early neuroepithelia, ENE) were formed. To generate caudalized neural 
progenitors, ENEs were cultured with RA (0.1 mM) for 1 week. Caudalized NE 
cells were liberated from the surface of the flasks, collected, and resuspended in 
flasks with neural induction medium. These aggregates were treated with retinoic 
acid (RA) and sonic hedgehog (SHH) to induce further differentiation, through a 
motor neuron progenitor (MNP) stage and finally into spinal motor neurons by 
day 33 in culture. 
  
RNA-seq library preparation 
 
To collect RNA, cells from culture dish wells were treated with 1 mL TRIzol 
reagent (Invitrogen). Total RNA extracts were treated with DNase and analyzed 
by Nano-drop spectrophotometer and run on a 2% agarose gel to ensure quality. 
 7.5 ug of total RNA from each sample were used to construct cDNA libraries 
using the Illumina mRNA-seq sample preparation kit. Briefly, poly(A)+ RNA 
molecules were isolated through 2 rounds of selection with oligo-d(T) beads. The 
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RNA was then chemically fragmented, precipitated, and reverse-transcribed to 
form double-stranded cDNA. End-repair, addition of an adenine nucleotide, and 
paired-end adapter ligation were then performed and adapter-ligated libraries 
were gel-purified (isolation of ~300 bp fragments). PCR was then performed to 
amplify the cDNA constructs, and libraries were again gel-purified.   
 
Sequencing & Data Analysis 
Libraries were clustered onto flowcells and single-read, 76-bp sequencing 
was performed using the Illumina Genome Analyzer IIx. Raw sequence reads 
have been deposited into GEO (Accession number XXXXXX).  Bowtie 
(Langmead et al. 2009) was used to simultaneously align 75-bp reads trimmed 
from the 3’ end to a combined index of the human genome (2009 release 
(hg19/GRCh37)), and all annotated splice junctions in hg19.  The splice junction 
index was created by extracting exonic sequences from UCSC, via Galaxy 
(http://usegalaxy.org), and assembling them into exon-exon junctions consisting 
of 69 nt of each joined exon, ensuring a minimum of 6 bp overlap during the 
alignments. Reads that mapped uniquely, with up to 2 mismatches, were 
accepted for downstream analysis. Custom perl scripts were used to convert 
Bowtie outputs into sam format for gene and transcript quantitation using 
Cufflinks (Trapnell et al. 2010). Cufflinks outputs were converted into tables 
representing gene-, transcript start site-, and transcript-level expression values 
(“FPKM,” or Fragment reads Per Kilobase of fragment model per Million mapped 
reads) with respect to all genes (26,702) across all samples in the neuronal 
differentiation timeseries.  Global gene expression profiles were compared, pair-
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wise, between all sequenced lanes, and Pearson correlation tests performed. 
 Lanes showing Pearson R2 ≥ 0.95 were merged into final sample datasets; 
these compiled reads were then re-aligned and analyzed using the methods 
described above.  Genes were considered to be “expressed” only if at least one 
sample scored FPKM ≥ 1.0 (14,899 genes).   
Cuffdiff was used to detect significantly-changing genes and transcripts at 
each stage of differentiation, as well as those that demonstrated consistent 
changes over multiple stages (e.g. from H9 to early neuroepithelium). In order to 
analyze genes showing developmentally dynamic expression patterns, 
expression values were further standardized by “Z-Scoring” sample FPKM values 
with respect to each gene’s average FPKM across all samples.  Dendrogram 
“heatmaps” were created using the free software Cluster 3.0 (EisenLab).  For 
initial analysis of differential expression across the timeseries, the dataset was 
filtered to include only those genes whose expression was significantly different 
between any two samples.  Gene Ontology analysis of co-expressed genes was 
performed using FuncAssociate (http://llama.mshri.on.ca/funcassociate/); the 
comparison “gene space” was the list of all genes expressed at FPKM ≥ 1.0 in 
any of the stages being compared.  Pathway analysis on significantly-changing 
genes was performed using the Panther Pathway database 
(http://pantherdb.org).  Signaling pathway genelists were obtained from the 
KEGG protein database (http://www.genome.jp/kegg/pathway.html). 
To determine the extent of AS, both overall and in individual samples, we 
designed custom perl scripts.  Genes were categorized as alternatively spliced if 
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2 or more transcripts associated with that gene were expressed, with at least one 
transcript at FPKM ≥ 1 and a second transcript expressed at ≥ 5% of the major 
transcript’s FPKM.  This analysis was performed both within samples and across 
the entire timeseries.  Alternative splicing “across the timeseries” was defined as 
expression -- at FPKM ≥ 1 -- of two distinct transcripts of a given gene in any 
combination of samples.  The number of alternatively spliced genes, as defined 
above, was compared to the total number of genes annotated as comprising 
multiple transcripts, with at least one transcript expressed at FPKM ≥ 1, as a 
measure of “isoform diversity.” 
For further analysis of splicing events, we designed custom perl scripts to 
examine cassette exon- and junction-specific expression changes throughout the 
timeseries.  We also used the Mixture of Isoforms (MISO) software (Katz et al. 
2010), available from the Burge Laboratory (http://genes.mit.edu/burgelab/miso/), 
to analyze the splicing patterns of ~100,000 splicing events in the human 
genome, as identified in Wang et al. 2008.  A subset of the events identified in 
this manner was validated by semi-quantitative RT-PCR.  Primer sequences for 
PCR reactions can be found in supplemental data. 
  
Results 
  
RNA-seq at multiple stages during motor neuron differentiation from 
hESCs 
 
To elucidate the gene expression and splicing changes that occur during 
neural differentiation, we subjected H9 hES cells to a protocol optimized for 
differentiation into spinal motor neurons as described previously (Li et al. 2005; Li 
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et al. 2008). This paradigm involves multiple stages including neural induction (to 
form neuroepithelial cells), neural patterning (to form the caudalized neural 
progenitors), and motor neuron specification (Figure 2.1A). The first stage to 
initiate the differentiation of hESCs was to detach ESCs from the feeder layer 
and suspended these cells in hES medium where they formed ESC aggregates 
(Figure 2.1B). The early NE (primitive NE, ENE) cells were positive for PAX6, a 
marker for NE cells (Figure 2.1C). With further culture, ENE organized into more 
mature rosette-like structure and formed definitive NE (also called later neural 
precursors, LNP; Figure 2.1A).  To specify spinal motor neurons, we first 
generated caudalized neural precursors (LNP-RA) by culturing primitive NE cells 
with RA for 1 week (Figure 2.1B).  Primitive NE cells were also cultured with 
FGF8 (LNP-FGF8) or basic medium (LNP-Control) for 1 week to generate other 
region-specific progenitors. The caudalized neural precursors were further 
specified into spinal motor neuron progenitors (OLIG2 expression peaked at day 
26, Figure 2.1D) and postmitotic motor neurons (HB9 expression peaked at day 
33, Figure 2.1E) in the presence of RA and SHH. This culture system of 
generating neural lineage and spinal motor neurons mimicked the temporal 
progression in vivo development. 
We collected samples at several time-points (day 0, 6, 10, 17, 26, and 33) 
throughout differentiation which represent the important stages during the 
development of neural lineage and spinal motor neurons and performed RNA-
Seq on poly(A)+ RNA isolated from these samples. Between 35 and 71 million 
sequence reads were generated from each sample, for a total of 389.9 million  
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Figure 2.1. Characterization of motor neuron differentiation cultures. (A) a 
schematic protocol of spinal motor neuron differentiation from hESCs.  (B) Phase 
contrast images showing the differentiation of NE cells from hESCs. (C) NE cells 
were positive for PAX6. (D, E) Immunostaining showing the generation of 
OLIG2+ motor neuron progenitors (D) and HB9+ post-mitotic motor neurons (E) 
at 26-day and 33-day after differentiation from hESCs. Blue color indicates 
Hoechst-stained nuclei. Bars, 20 (B) and 50 (C-E) µm. 
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reads. We obtained at least 19.8 million uniquely mapped reads per sample. 
 Approximately 20-25% of the uniquely mapped reads aligned to splice junctions.  
We next used Cufflinks to quantitate expression levels for all genes and 
transcripts in the hg19 UCSC (GRCh37/hg19) annotation. We used a cutoff of 
FPKM ≥ 1 to assign genes as being detectably expressed.  Using this criteria, 
between 12,997 (H9 ES) and 13,492 (LNP-control) genes were expressed at 
each time point.  11,292 genes were detectably expressed in all 8 samples while 
9,460 annotated genes were not detectably expressed in any of the samples we 
analyzed.   
 
Analyzing differential gene expression 
We next used CuffDiff to identify 2,503 genes whose expression is 
significantly different between any two samples and performed unsupervised 
hierarchical clustering (average linkage and k-means clustering with (k=10)) to 
identify sets of co-regulated genes. Importantly, known marker genes are 
enriched at the appropriate time points.  For example, a cluster of 433 genes that 
are enriched in undifferentiated hES cells (H9, 0d) includes the known stem cell 
markers Hesrg, Nanog, Oct4, and Tdgf1 (Figure 2.2A). Other “traditional” hESC 
markers show distinct expression patterns.  For instance, Klf4, whose exogenous 
expression has been used to reprogram somatic cells into iPSC, is highly 
expressed in stem cells and embryoid bodies but is silenced at later stages of 
differentiation. Tert, which encodes reverse transcriptase component of 
telomerase, and whose expression has been used as a marker for pluripotency,  
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Figure 2.2.  (A) Heatmap representing unsupervised hierarchical average 
linkage clustering of 2,503 genes whose expression is significantly different 
between any two samples.  hES and neural marker genes are expressed in 
appropriate patterns.  (B-D) RT-PCR validation of observed expression patterns. 
(B) ENE markers Pax6 and Sox1 are not detected in hESC, but are upregulated 
in EB and ENE cells, respectively.  (C) Motor neuronal markers show 
upregulation later in differentiation.  HoxC5 is silenced until the LNP stage, Olig2 
is upregulated in MNP and MN cells, and Mnx1 is only expressed in MN cells.  
(D) Expression of Cdh2, Asap2, Grk5, and Tcf12 is activated in EB cells and 
remains high throughout differentiation, while PcdhB13, Cdc14A and PcdhB11 
show variable expression during differentiation with peak expression at the EB 
stage. 
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shows enriched expression from undifferentiated H9 cells through the early 
neuroepithelial stage before being silenced.  
Conversely, neural lineage marker genes were activated at later 
differentiation timepoints.  A number of homeobox genes (including Hoxb4, 
Hoxa2/3/5 and Hoxc4), specific for caudalized cells, were upregulated beginning 
at the LNP stage (Figure 2.2A).  Notably, these genes showed higher expression 
in RA-treated cells than in control or FGF8-treated cells.  Motor neuronal 
progenitor marker genes Olig1 and Olig2 were dramatically upregulated in the 
MNP cell population (Figure 2.2A).  Finally, highly neuronal specific genes like 
Chat, Dcx, and NeuroG3 were not detectably expressed until cells had 
differentiated terminally into spinal motor neurons (Figure 2.2A).   
 
Validation of differential expression patterns 
We performed RT-PCR to validate the gene expression data obtained by 
RNA-Seq.  We first examined the expression of genes related to neural induction 
and motor neuron differentiation. Expression of Pax6 and Sox1, markers for ENE 
cells, was not detected in hESCs but significantly increased by the ENE stage 
(Figure 2.2B).  Hoxc5, Olig2, and Mnx1, markers for spinal motor neurons, were 
highly expressed by the LNP, MNP and MN stages, respectively (Figure 2.2C). 
These data are in agreement with the RNA-seq data (Figure 2.3) as well as the 
characterization of these cultures. We then validated the expression of a subset 
of genes that demonstrate highly dynamic expression through early neural 
differentiation (day 0 to day 17 samples). For example, the expression level of 
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Figure 2.3.  RNA-Seq and RT-PCR analysis of gene expression showed high 
correlation.  In some cases, PCR captured the general pattern of expression but 
was unable to detect the subtle expression differences between samples.  
(A) RNA-Seq and RT-PCR analysis of Pax6.  Gene expression is low in H9 
cells and increases dramatically in EB cells.  Expression remains high as 
cells continue to differentiate down the neural lineage, but decreases during 
the last two steps of differentiation.  RT-PCR confirms the observed pattern 
of gene expression. 
(B) RNA-Seq and RT-PCR analysis of Sox1.  Gene expression is undetectable 
in H9 and EB cells, with an increase to detectable levels at the ENE stage.  
There is a slight decrease in expression at LNP-RA stage, then a large 
increase in MNP cells; expression remains robust in MN cells.  RT-PCR 
confirms the general pattern of gene expression, but does not capture the 
subtle changes between samples. 
(C) RNA-Seq and RT-PCR analysis of Hoxc5.  Gene expression is 
undetectable in H9, EB, and ENE cells. Expression reaches a detectable 
level in LNP-RA cells, then is dramatically upregulated in MNP cells, and 
remains high in MN cells.  RT-PCR confirms expression in the final three 
developmental stages, but does not capture the differential expression 
between the three. 
(D) RNA-Seq and RT-PCR analysis of Olig2.  Gene expression is undetectable 
until cells differentiate into the MNP stage.  Expression is reduced, but still 
detectable, in MN cells.  RT-PCR confirms the general expression pattern, 
but does not capture the more subtle changes. 
(E) RNA-Seq and RT-PCR analysis of Mnx1.  Gene expression is low until cells 
terminally differentiate into MN.  RT-PCR confirms the observed pattern of 
gene expression. 
(F) RNA-Seq and RT-PCR analysis of Cdh2.  Gene expression is low in H9 
cells and increases dramatically in EB cells.  Expression remains high as 
cells continue to differentiate down the neural lineage.  RT-PCR confirms 
the observed pattern of gene expression. 
(G) RNA-Seq and RT-PCR analysis of PcdhB11.  Gene expression is low in H9 
cells and increases dramatically in EB cells.  Expression remains high as 
cells continue to differentiate down the neural lineage.  RT-PCR confirms 
the observed pattern of gene expression. 
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Cdh2, Asap2, and Grk5 increased during neural differentiation and was then 
maintained at a high level for the remainder of the time course (Figure 2.2D), 
while PcdhB13, Cdc14A and PcdhB11 expression peaked at day 6 and was 
lower at other timepoints during differentiation (Figure 2.2D). In summary, our 
validation experiments had a high degree of concordance with the RNA-Seq 
data.  
 
Analysis of co-regulated gene clusters 
We used Gene Ontology and the Panther Pathway Database to 
understand the coordinated patterns of gene expression.  The 433-gene hESC-
enriched cluster was enriched in genes involved in plasma membrane 
organization and remodeling, chemical homeostasis and immune 
system/defense response.  The expression of 164 genes was enriched in 
embryoid bodies – over-represented GO terms included developmental 
processes (“mesenchymal cell development,” “cell differentiation” and 
“anatomical structure morphogenesis”) as well as many involved in gene 
expression (“sequence-specific DNA binding” and “regulation of transcription”).  
Late neural precursor stage-cells (LNP-RA) showed enriched expression of 
genes associated with extracellular matrix deposition and cell adhesion -- given 
that cells at these stages grow in rosettes, these pathways would be extremely 
important for appropriate organization of cellular structures. The cluster of genes 
that are upregulated in MNP and MN cells, or “motor neuron specification” genes, 
is enriched in transcription factors and a large number of elements of WNT 
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signaling.  As cells at this stage are progressing toward terminal differentiation 
and loss of mitotic potential, we find that genes that function to regulate the cell 
cycle are also enriched in this cluster.  Finally, GO analysis revealed that the 
323-gene cluster upregulated in mature MN cells was enriched in genes 
associated with virtually every aspect of neuronal function, including ion channel 
activity, neurotransmitter transport, secretion and release, “axon guidance,” 
“synaptosome,” etc.,  are highly enriched in MN cells.   
 More detailed analysis of the changes occurring on a step-by-step basis 
provides more validation of our study.  There was a large dynamic range of 
stage-specific changes, with 157 (motor neuronal progenitors to spinal motor 
neurons) to 526 (early neuroepithelium to RA-induced late neural precursors) 
genes increasing at different transitions, and 230 (ENE-LNPra) to 607 (MNP to 
MN) genes demonstrating significant decreases in expression (Figure 2.4).  
Gene Ontology analysis demonstrated enrichment of various, distinct pathways 
and processes within these different transitions.  While some of these were 
consistent with the GO terms associated with stage-specific enrichment 
mentioned above, novel terms appeared in this analysis.  The 268 genes 
showing significant increases in expression from H9 to EB are enriched in genes 
associated with cell adhesion, multicellular organism development and cell 
differentiation, among others (Figure 2.4).  Panther Pathway analysis reveals an 
enrichment of genes associated with WNT and cadherin signaling.  Genes that 
decreased (262) are associated with negative regulation of cell adhesion 
(bolstering the effect of the concomitant increase mentioned) and angiogenesis. 
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Figure 2.4.  Panther pathway DB (http://pantherdb.org) analysis of significantly 
changing gene clusters.  The groups of genes deemed significantly up- and 
downregulated during each transition were submitted to the Panther Gene 
Expression Analysis module.  The list of all genes expressed at or above FPKM 
1, in at least one of the samples represented by the given transition, was used as 
the reference genespace.  Enriched pathways for up- and downregulated genes 
are shown above and below the chart, respectively.  Only significantly enriched 
pathways (p < 0.05) are shown. 
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From EB to ENE, a group of 212 genes increased with associations to collagen, 
PDGF binding, and many extracellular matrix-associated processes.  Panther 
analysis revealed enrichments in integrin, WNT and cadherin signaling (Figure 
2.4). Meanwhile, the 248 genes that decreased are associated with many 
functions, including virtually all aspects of ribosomal assembly and translation.  
The ENE-LNPra transition included 526 genes that significantly increased.  
These included enrichment of genes associated with the ribosomal assembly 
pathways that had just decreased during the previous transition, as well as a 
number that function in retinoid metabolism, which is logical given that these cells 
have been treated with retinoic acid.  Of the 230 genes that decrease during this 
transition, only the MCM complex (involved in DNA replication initiation and 
elongation) shows enrichment.  Panther DB analysis showed an enrichment in 
genes associated with nicotinic acetylcholine, cadherin and WNT signaling.  
From the LNP to the MNP stage, 311 and 607 genes, respectively, show 
significant increases and decreases (Figure 2.4).  GO terms associated with the 
increasing genes include anterior-posterior pattern development, regionalization, 
neuron differentiation and the regulation of various neuronal processes 
(axonogenesis, projection, neurogenesis).  There is also a significant enrichment 
of genes involved in WNT, Notch, cadherin and JAK/STAT signaling pathways, 
as well as axon guidance mediated by semaphorins.  Once again, elements 
associated with ribosome assembly and translation were enriched in the 
decreasing gene set, along with genes involved in collagen and ECM interaction 
(including PDGF- and fibronectin-binding), as well as a number of genes involved 
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in integrin signaling.  In the final transition from MNP to MN, 157 genes 
significantly increased, with enrichment in those associated with glucose 
catabolic processes, axon and neuron cell body, neuron projection and response 
to external stimuli (Figure 2.4).  Pathway enrichment included glycolysis, 
cytoskeletal regulation by Rho-GTPase, axon guidance mediated by 
SLIT/ROBO, and endocannabinoid and glutamate receptor signaling.  A larger 
group of 276 decreased, with enrichment in MCM complex elements, ribosomal 
assembly and translation, and many elements of the cell cycle (Figure 2.4).  
Indeed, factors involved in M-G1 and G-S transitions, and S phase processes, all 
showed significant decreases.  The downregulated gene set also included an 
enrichment for factors involved in de novo pyrimidine and purine synthesis, along 
with FAS signaling.  As mentioned above, these cells are terminally differentiated 
and exiting the cell cycle, with no need for further DNA replication, providing a 
rationale for these observed changes.  Further, neurons are highly dependent on 
glucose metabolism -- a possible explanation for the upregulation in the glycolytic 
pathway. 
A much smaller set of genes showed more drawn out, consistent patterns 
of change.  A range of 14 (ENE-MNP) to 42 (EB-LNPra) genes showed 
significant increases across 2 transitions, while 11 (ENE-MNP) to 65 (LNPra-MN) 
decreased (data not shown).  Most of these groups did not demonstrate 
enrichment of GO terms, but the few that did stand to reason.  The 42 genes 
upregulated from EB-LNPra are enriched in ECM-associated processes including 
collagen & its organization, peptide cross-linking, and PDGF- and IGF-binding.  
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The 30 genes that increase from LNPra-MN show enrichment for A-P pattern 
formation.  This is a logical finding, as the model of CNS development begins 
with the patterning of cells that are believed, by default, to have an anterior 
neural phenotype.  Exposure of these cells to subsequent signals, including sonic 
hedgehog and retinoic acid, drives them into more posteriorized/caudalized 
regional cellular subtypes.  The 65 genes that showed a significant decrease 
during these same two transitions (from LNPra-MN) show enrichment for 
ribosomal assembly and translation.  While these cells are undergoing terminal 
maturation, there is a high amount of translation in neurons, both in the cell body 
and locally in the dendrites and axons.  It could be that the ribosomal structures 
are highly stable in these cells, with a low turnover rate, requiring less basal 
transcription of ribosomal protein-encoding genes. 
Only 3 genes significantly increased through the first 3 transitions from 
H9-LNPra: Mdk (midkine, also known as “neurite-promoting growth factor 2”), 
Sfrp2 (soluble frizzled-related protein 2) and Silv.  The SFRP2 protein 
antagonizes WNT signaling; importantly, WNT inhibition has been shown to be 
important in neural patterning in vivo in frogs, chicks, mice and in human ES 
cells.  Similarly, 3 genes are significantly upregulated from EB-MNP: the non-
coding RNA BC141932, with no known orthologues, Rab9a, which encodes a 
RAS oncogene-family GTP-binding protein, and Nr2f1.  Nr2f1 is an interesting 
case, as this transcription factor (the protein is also known as COUP-TFI) was 
recently shown to be crucial in the neurogenic-to-gliogenic switch seen in aging 
neural progenitor cells (Naka et al. 2008).  This function is conserved between 
 97 
the mouse and human orthologues.  Only 2 genes show significant increases 
from ENE to MN.  These are Hsn2 (hereditary sensory neuropathy 2, a gene 
thought to be important for the maintenance of sensory neurons and Schwann 
cells) and LOC400043, a predicted gene product with no known orthologues, 
located near the Hoxc4/5 cluster, that is annotated both as non- and protein-
coding. 
Similarly, only 3 genes showed a significant decrease in expression 
across the first 3 transitions, Capn12 (calpain12, a calcium-sensitive protease), 
Dppa4 (developmental pluripotency-associated 4) and Dnmt3b, the de novo DNA 
methyltransferase known to be highly expressed in hES cells.  Dppa4 is also 
known as a stem cell marker, is a transcriptional target for OCT4/SOX2 dimers, 
and, while dispensable for stem cell maintenance, is crucial for proper embryonic 
development in mice.  2 other genes, AK294004 and Lin28, showed consistent 
decrease from EB to MNP stages, and AK294004 was the only gene that 
showed significant decrease from ENE to MN stage.  Lin28 (Figure 2.5) is known 
to be highly expressed in stem cells and was used as a reprogramming factor in 
the derivation of human iPS cells.  It is dispensable for reprogramming, but is 
thought to boost reprogramming efficiency.  AK294004 is an antisense RNA 
located in the cyclin D1 3’ untranslated region (UTR).  Cyclin D1 is a crucial player 
in the G1 to S phase cell cycle transition.  Very little information regarding 
AK294004 or its function is available.  It could be involved in an RNAi pathway to 
decrease cyclin D1 expression.  Our results indicate that cyclin D1 mRNA 
expression is relatively flat across our timeseries (as are expression of Cdk4 and  
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Figure 2.5.  RNA-Seq analysis of the Lin28 gene.  Lin28 shows significant 
decreases in expression level in each transition from EB to MNP cells.  This gene 
is known to be highly expressed in stem cells and was used as a reprogramming 
factor in the derivation of human iPS cells. 
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Cdk6, the two kinases strongly regulated by the cyclin), so decreased expression 
of a ncRNA that normally decreases cyclin D1’s expression would be predicted to 
result in disinhibition -- an increase in cyclin D1 expression or activity.  However, 
given that our GO analysis indicates that many elements of the cell cycle are 
decreased in these cells, cyclin D1’s role may be nonetheless negated.  
Alternatively, there could be other post-transcriptional, translational or post-
translational control over cyclin D1 in the context of mature, spinal motor neurons. 
 
Analysis of signaling pathways implicated in neural differentiation 
Our cluster analysis, detailed above, revealed the coordinated expression 
patterns of genes associated with various signaling pathways.  We thus 
performed a more detailed analysis of individiual signaling pathways, including 
unsupervised hierarchical clustering of factors involved in WNT, TGF-beta, FGF, 
Notch, integrin and JAK/STAT signaling (Figure 2.6). 
Fgf signalling is known to be important for neural differentiation.  
Accordingly, many genes encoding components of the Fgf signalling pathway are 
most highly expressed in the early stages of neural patterning.  For example, 
Fgf8 expression is low in H9 cells but increases across the next two transitions to 
reach peak expression in ENE cells.  Fgf3 shows a similar, but delayed pattern, 
where expression is low in H9 and EB stages, but increases dramatically over 
the next two transitions to reach its peak in the late neural precursors.  Fgf9 also 
shows an increase in expression at the ENE stage, although its peak comes 
later.  All together, there are 9 elements of Fgf signaling that show enriched 
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Figure 2.6.  Unsupervised hierarchical clustering of factors involved in WNT, 
TGF-beta, FGF, Notch, integrin and JAK/STAT signaling pathways.  All clustered 
genes demonstrated significantly different expression levels between 2 samples 
in the timeseries.  The vast majority of genes show upregulated expression at 
some point during neural differentiation.  Genelists were obtained from the KEGG 
protein database.    
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expression during neural differentiation, and all of them show increases in 
expression during early or late neural differentiation (Figure 2.7A). 
One of the earliest discoveries regarding signaling in early patterning of 
the CNS was the observation that inhibition of BMP signals was crucial to induce 
formation of the neuroepithelium.  The LRP2 protein, also known as Megalin, 
plays a role in the endocytic uptake and degradation of BMP4 (Spoelgen et al. 
2005).  We found that Lrp2 expression increased dramatically in the ENE stage 
and remained high in all LNP samples before being silenced in MNP and MN 
cells.  We performed unsupervised hierarchical clustering of all known genes in 
the TGF-beta signaling pathway, and found 16 genes that were expressed at 
significantly different levels between any two samples; all but 2 of these showed 
a pattern of increasing expression during early or late neural differentiation 
(Figure 2.7B). 
Likewise, previous work has demonstrated that blocking Wnt signaling is 
also important in the process of early neural differentiation, while upregulated 
Wnt signaling subsequently drives cells into a more caudalized (and dorsalized) 
phenotype.  Several Wnt genes show upregulation during this developmental 
process (7 Wnt molecules reach peak expression at ENE or LNP stages), and 
the frizzled WNT receptors Fzd1 and Fzd5 also show significant increases in 
expression in early neural patterning, with peaks at the LNP and ENE stages, 
respectively (Figure 2.7C).  There are also a number of antagonists that increase 
in expression during early and late patterning, including Sfrp1, Sfrp2, Dkk1, Dkk2 
and Dkk3.  Our data indicate that Wnt signaling may be important in the final 
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Figure 2.7.  Unsupervised hierarchical clustering of factors involved in (A) FGF, 
(B) BMP (TGF-beta), (C) WNT and (D) Notch signaling pathways.  All clustered 
genes demonstrated significantly different expression levels between 2 samples 
in the timeseries.  The vast majority of genes show upregulated expression at 
some point during neural differentiation.  Genelists were obtained from the KEGG 
protein database.  
 105 
 
 106 
stages of motor neuronal maturation, as Wnt4, Wnt5a and Wnt7a all reach peak 
expression in MNP or MN cells.  Depending on the specific Wnt molecule, we 
detected differential enrichment in the various regionalized LNP samples.  For 
example, Wnt5a and Wnt2b are expressed highest in the RA-treated LNP 
sample, while Wnt5b, Wnt7b, Wnt6, Wnt10a, Wnt1 and the receptors Fzd5 and 
Lrp4 are depleted, relative to control or FGF8-treated cells.  Wnt9b is highly 
expressed in all LNP samples.  Likewise, the antagonists showed regional 
expression trends.  Sfrp2 was highly expressed in all LNP samples, while Sfrp1 
was relatively enriched in control (forebrain) cells and Sfrp5 was highest in RA-
treated cells (Figure 2.7C). 
Finally, Notch signaling is known to be important in neural differentiation 
and the neuro-glial switch.  While Notch mRNA expression did not change 
significantly during the timeseries, expression of activating ligands did.  Dll1 was 
depleted in H9 and EB-stage cells but high in all subsequent stages (with the 
exception of only the RA-treated LNP cells); Dll2 and Dll3 were both highly 
upregulated in MNP and MN cells (Figure 2.7D). 
 
Identification of cell surface markers for caudalized neural progenitors 
 Stem cells begin to express region-specific genes once they are induced 
to differentiate into forebrain, midbrain, or hindbrain progenitors. In the more 
rostral groups of cells (control and FGF8 groups), genes such as Otx2 (a 
transcription factor expressed by forebrain and midbrain cells) and Foxg1 (a 
marker for forebrain) are expected to be highly expressed. The RNA-Seq data 
 107 
were consistent with this (Figure 2.8A). In the RA-treated LNP cells (caudalized 
neural progenitors), posterior genes (i.e., HoxB1, HoxB4, HoxB6, HoxB8, HoxC5, 
and HoxC8) were all upregulated, while anterior genes (i.e., Otx2 and FoxG1) 
were downregulated (Figure 2.8A). RT-PCR for Otx2, HoxB1, and HoxB4 are 
consistent with the RNA-Seq data (Figure 2.8B). The rostral neural progenitors, 
with further culture, expressed OTX2 protein and were negative for HOXB4 
protein (Figure 2.8C). In contrast, the caudal neural progenitors were positive for 
HOXB4 protein but negative for OTX2 protein (Figure 2.8C), further confirming 
their identities. 
 
Identification of differential alternative splicing  
We analyzed alternative splicing throughout neural differentiation in two 
ways.  First, we analyzed the diversity of transcripts expressed throughout the 
differentiation time course as calculated using Cufflinks.  We determined that 
between 8,118 and 8,410 genes gave rise to at least two transcripts where the 
expression of one isoform had an FPKM≥1 and at least one other isoform had an 
FPKM at least 5% as abundant as the most abundant isoform.  This corresponds 
to between 83% and 85% of all expressed, annotated multi-transcript genes as 
being alternatively spliced within each sample.   
Analyzing across samples, we determined that at least 10,521 genes are 
alternatively spliced, giving rise to at least 45,685 distinct transcripts; there are 
11,295 annotated “alternatively spliced” genes expressed at some point during 
the timeseries. Thus, by this analysis, 93% of these genes demonstrate 
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Figure 2.8.  Analysis of differential gene expression in regionalized late neural 
precursor (LNP) cells.  (A) RNA-Seq analysis of genes with regionally specific 
expression.  The rostral markers Otx2 and HoxG1 are expressed at a lower level 
in RA-treated LNP cells than in control or FGF8-treated cells.  Caudally-
expressed genes, like HoxB1, HoxB4, HoxB6, HoxB8, HoxC5 and HoxC8, are 
highly enriched in RA-treated cells relative to control or FGF8-treated cells.  All 
heatmap values are expressed as log-based fold changes, relative to control 
LNP cells.  (B) RT-PCR for Otx2, HoxB4 and HoxC5 show expression levels that 
are consistent with RNA-Seq data.  (C) Immunostaining showing differential 
expression of OTX2 and HOXB4 proteins in control or RA-treated LNP cells. 
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alternative splicing during the process of neural differentiation. We used a 
stringent threshold for transcript expression, so low-expression genes are under-
represented in this analysis. Additionally, genes with a large number of possible 
transcripts, or low- or medium-level expression genes with many transcripts 
expressed at similar levels will be missed. Using a more stringent cutoff of 
FPKM≥10, the numbers of expressed genes and transcripts decrease. Of more 
interest is the fact that the AS extent numbers show more of a trend with this 
cutoff. While 76.5% of annotated multi-transcript, expressed genes show multiple 
isoforms in H9 cells, this proportion shows a general increase through 
differentiation, and 80.4% of such genes show multiple isoforms in spinal motor 
neurons. This result confirms previous findings of increased preponderance of 
alternative splicing in neurons. 
We also analyzed alternative splicing using Mixture of Isoforms (MISO), 
which analyzes individual alternative splicing events within and between samples 
(Katz et al. 2010). This model uses a Bayesian based algorithm to determine 
significantly changing events. We used MISO to analyze the ~100,000 splicing 
events identified in Wang et al., and successfully detected 76,019 of these 
events in at least one sample.  Further, we identified 8,879 events that were 
spliced in significantly different patterns between any two samples (Table 2.1).  
We calculated global correlation values for all splicing events of each type.  In all 
cases, samples are highly correlated with immediately upstream and 
downstream developmental stage samples, and correlation decreases as 
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Table 2.1.  Summary of MISO analysis of alternative splicing patterns in the 
neural timeseries.  We analyzed 108,354 splicing events identified in Wang et al. 
2008.  We detected 76,019 events in at least one sample in the timeseries.  Of 
these, we detected 8,879 events that showed significantly different splicing 
patterns between any two samples. 
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 developmental distance increases (Figure 2.9, Figure 2.10).  We picked out the 
cassette exons at the 95th percentile of log-transformed BF values, for which all 
samples had enough data to determine percent spliced in (PSI) values, Z-scored 
the PSI values, and clustered these by the average linkage distance method, 
using Cluster 3.0 (Figure 2.11A). We identified a group of 42 cassette exons 
demonstrating highly enriched inclusion/exclusion (i.e. high/low relative PSI) in 
motor neurons.  We extracted the sequences of the cassette exons plus 500 bp 
up- and downstream from UCSC via Galaxy, and mined these sequences for 
enriched splicing factor binding sites, using the motif finder MEME and custom 
analyses.  Analysis through MEME detected a high enrichment of poly-T sites 
(which could represent binding sites for nPTB, the neuronal-specific 
polypyrimidine tract binding protein) (data not shown).  Along with these 42 
genes, we added genes from clusters showing relative exon depletion in MN 
cells and cross-referenced the final list of 154 genes with previously validated 
NOVA and FOX1/2 targets (from Ule et al. and Zhang et al.).  We identified 4 
NOVA- and 22 FOX1/2-regulated targets among this set (data not shown).  
Further analysis is required to validate additional targets of these, and other, 
splicing factors active in neuronal cells. 
As in our gene-level analysis, we picked a subset of dynamic alternative 
splicing events in early neural differentiation to validate by RT-PCR. Of the 23 AS 
events we examined, we observed consistent results -- e.g. a cassette exon 
showed decreased expression both in sequence data and PCR -- for 21 (91%). 
For example, we identified a splicing change in the Ralgps2 gene, a guanine  
 114 
Figure 2.9.  Scatterplots representing percentage spliced in (PSI) values for all 
detected splicing events.  In all cases, H9 splicing pattern was compared to each 
of the 5 subsequent developmental stage cells. (A) Skipped (cassette) exons, 
alternative 5’ splice sites and alternative 3’ splice sites.  (B) Alternative first 
exons, alternative last exons and tandem 3’ UTR (alternative cleavage and poly-
adenylation) events.  (C) Mutually exclusive exons and retained/unprocessed 
introns. 
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Figure 2.10.  Correlation heatmap for 31,479 skipped (cassette) exon events 
detected in any timeseries sample.  All pairwise sample comparisons are shown.  
Samples show greatest correlation with immediately upstream and downstream 
developmental stages, and correlation values decrease as developmental 
distance increases. 
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Figure 2.11. Detailed analysis of differentially spliced events in the neural 
differentiation timeseries.  (A) We picked out the cassette exons at the 95th 
percentile of log-transformed BF values, for which all samples had enough data 
to determine percent spliced in (PSI) values, Z-scored the PSI values, and 
performed unsupervised hierarchical clustering, by the average linkage distance 
method, using Cluster 3.0.  (B) RNA-Seq analysis of a cassette exon event in 
Ralgps2.  This cassette is nearly universally included in hESC gene products, but 
shows increasing exclusion as the cells differentiate into the neural lineage, and 
is rarely included in MN cells.  (C) RT-PCR analysis validates the observed 
splicing pattern. 
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exchange factor (GEF) involved in the GDP/GTP cycling of a RAL GTPase. 
Sequencing results indicate that the PSI value for a single Ralgps2 cassette exon 
dropped dramatically - from 86% to 9% inclusion - through the timeseries (Figure 
2.11B). Our PCR results were highly consistent with sequencing results, as the 
PSI values were extremely similar for each developmental stage (Figure 2.11C).  
This cassette exon encodes amino acids 416-442 of the RALGPS2 protein, 
although this stretch does not contain any annotated domains or regions.  We 
identified other splicing events involving changes in the 5’ UTR and/or coding 
regions of the genes in question (Figure 2.12).  We detected a dramatic change 
in usage of the mutually exclusive exons in Pkm2 (a “muscle-specific” pyruvate 
kinase) during neural differentiation (Figure 2.12A).  Particular exon choice 
determines the intersubunit contact region and ablates phospho-tyrosine and N6-
acetyllysine sites. Further, it could affect one of the two fructose-bisphosphate 
(FBP) binding sites, a crucial regulatory mechanism for this enzyme. 
We were also able to detect dynamic patterns in transcription initiation site 
usage. Our script identified, among other events, a switch in the predominant 
transcription initiation site for Dclk1 (serine/threonine protein kinase) during 
neural differentiation (Figure 2.12H).  We detected a dramatic trend toward 
usage of the “distal” initiation site (21% to 81% usage) as cells differentiated into 
the neural lineage.  This trend was also shown in RT-PCR validation (Figure 
2.12H).  This switch has important functional implications: transcripts originating 
at the distal site only will contain 2 DCX domains, as well as a proline/serine-rich 
region and 4 phosphoserine sites.  DCX domains, found in the neural-specific  
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Figure 2.12.  RNA-Seq analysis and RT-PCR validation of several identified 
events demonstrating differential splicing between samples in the timeseries.   
(A) Analysis of a mutually exclusive exon event in Pkm2.  As cells differentiate 
down the neural lineage, the exon 9A PSI increases.  RT-PCR analysis 
confirms this pattern of exon selection.  Pkm2 encodes the “muscle-
specific” variant of the pyruvate kinase enzyme.  This splicing change 
affects binding and regulation properties of this protein. 
(B) Analysis of a cassette exon event in HmgxB4.  As cells differentiate down 
the neural lineage, exon 5 PSI decreases.  RT-PCR analysis confirms this 
splicing pattern.  HmgxB4 encodes HMG box domain containing 4, a 
transcription factor. 
(C)  Analysis of a cassette exon event in Axl.  As cells differentiate down the 
neural lineage, exon 10 PSI increases.  RT-PCR analysis confirms this 
splicing pattern.  Axl encodes the AXL receptor tyrosine kinase. 
(D)  Analysis of a cassette exon event in Tbc1D23.  As cells differentiate down 
the neural lineage, exon 15 PSI increases.  RT-PCR analysis confirms 
this splicing pattern.  Tbc1D23 encodes the TBC1 domain family, member 
23 protein. 
(E)  Analysis of a cluster of cassette exons (exons 13-15) in Tcf7L2.  As cells 
differentiate down the neural lineage, the 2-exon (13-14) PSI increases.  
RT-PCR analysis confirms this splicing pattern.  Tcf7L2 encodes 
transcription factor 7-like 2, a downstream effector of WNT signaling. 
(F)  Analysis of a distinct cassette exon event in Tcf7L2.  As cells differentiate 
down the neural lineage, exon 3 PSI decreases.  RT-PCR analysis 
confirms this splicing pattern. 
(G) Analysis of a cassette exon event in St6galnac6.  As cells differentiate 
into the neural lineage, exon 2 PSI decreases.  RT-PCR analysis confirms 
this splicing pattern.  St6galnac6 encodes a sialyltransferase enzyme. 
(H)  Analysis of an alternative first exon event in Dclk1.  As cells differentiate 
down the neural lineage, there is increasing usage of the “distal,” or 
upstream, initiation site.  RT-PCR analysis confirms this pattern of 
initiation site usage.  Dclk1 encodes doublecortin-like kinase 1.  Choice of 
first exon affects inclusion of several protein domains. 
(I) Analysis of an alternative first exon event in Ugp2.  As cells differentiate 
down the neural lineage, there is increasing usage of the distal, or 
downstream, initiation site.  RT-PCR analysis confirms this pattern.  Ugp2 
encodes the UDP-glucose pyrophosphorylase 2 enzyme. 
(J) Analysis of an alternative first exon event in Prkar1B.  As cells differentiate 
down the neural lineage, there is increasing usage of the “distal,” or 
upstream, initiation site.  RT-PCR analysis confirms this pattern.  Prkar1B 
encodes the regulatory, type I beta subunit of the cAMP-dependent 
protein kinase (PKA). 
(K)  Analysis of an alternative first exon event in Diaph2.  As cells differentiate 
down the neural lineage, there is increasing usage of the proximal, or 
upstream, initiation site.  RT-PCR analysis confirms this pattern.  Diaph2 
encodes the diaphanous homolog 2 protein (Drosophila homology). 
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(L) Analysis of an alternative first exon event in Snrpn.  As cells differentiate 
down the neural lineage, there is increasing usage of the proximal, or 
upstream, initiation site.  RT-PCR analysis confirms this pattern.  Snrpn 
encodes the small nuclear ribonucleoprotein polypeptide N, and has an 
extremely complex pattern of alternative initiation sites and alternative 
splicing. 
(M) Analysis of an alternative first exon event in Nudt6.  As cells differentiate 
down the neural lineage, there is increasing usage of the “distal,” or 
upstream, initiation site.  RT-PCR analysis confirms this pattern.  Nudt6 
encodes the nudix (nucleoside diphosphate linked moiety X)-type motif 6.  
Choice of first exon has dramatic effects on protein composition. 
(N)  Analysis of an alternative last exon event in Ap1S2.  As cells differentiate 
down the neural lineage, the distal exon (represented by primer 1) is 
included more often, as a more proximal exon is increasingly excluded.  
RT-PCR confirms this pattern.  No product was obtained with primer 3.  
Ap1S2 encodes the adaptor-related protein complex 1 sigma 2 protein. 
(O) Analysis of a retained intron event in Hdac10.  As cells differentiate down 
the early neural lineage, the ratio of intron retention is differentially 
regulated.  This event was previously unannotated.  Hdac10 encodes 
histone deacetylase 10, a chromatin-remodeling enzyme. 
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doublecortin protein, are thought to bind microtubules and enhance 
polymerization.  Nudt6 (nudix-type motif 6, an antisense gene located near Fgf2) 
shows dynamic use of initiation sites, with an increase in the usage of the 
“proximal” site as cells differentiate.  This results in a drastic change to the 
protein, as ~500 nt that were previously 5’ UTR are incorporated into 169 amino 
acids of coding sequence in the NUDT6 protein.  Part of the nudix hydrolase 
domain is encoded by this region.  Other dynamic patterns of initiation site usage 
would affect transcriptional regulation by altering promoter composition and 
transcription factor binding sites (Figure 2.12M). 
 
Discussion 
 We set out to examine the dynamics of transcriptome expression in hES 
cells differentiating into the neural lineage. Microarrays show inherent drawbacks 
for expression analysis, especially in detecting splicing changes, so we used 
RNA-Seq.  We generated hundreds of millions of raw sequence reads and our 
results corresponded well with the expression of genes known to be expressed at 
various developmental stages.  We also observed a high degree of concordance 
between sequencing and PCR results.   
We detected thousands of genes demonstrating dynamic expression 
through the timeseries.  Analysis of genes showing differential expression across 
developmental transitions revealed enrichments of factors involved in important 
neural signaling pathways, including WNT, BMP, FGF, Notch, cadherin, and 
integrin.  These enrichments were found in genes upregulated in both early and 
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late neuronal development, indicating complex temporal regulation and, perhaps, 
distinct roles in early and late stages of differentiation.  Very few genes showed 
significant and consistent changes over many transitions, but those that do are 
typically known to be involved in functions related to the transitions in which they 
change.  For instance, we found that Nr2f1, encoding the COUP-TF1 
transcription factor, significantly increases in expression from embryoid body to 
motor neuronal progenitor stages.  Recent work has uncovered the crucial role 
the COUP-TF factors play in the neurogenic-to-gliogenic “switch” seen as 
progenitor cells age (Naka et al. 2008).  Expression of Sfrp2, a WNT-signaling 
antagonist, increased from H9 cells through the definitive neuroepithelial (LNP) 
stage; blockage of WNT signaling is known to be crucial for early CNS patterning 
in amniotes and anamniotes alike.  Expression of Dppa4 and Dnmt3b decreased 
significantly across the first three transitions.  Dppa4 is a stem cell marker, 
dispensable for pluripotency maintenance but important in differentiation (Madan 
et al. 2009).  Dnmt3b is a well-known de novo methyltransferase, responsible for 
epigenetic markings in early development (Okano et al. 1999, Chen et al. 2003).  
Many of these differentially-expressed genes known functions, but a great 
number have no known roles in neural differentiation and function.  An example 
is LOC400043, which shows significant upregulation from the early 
neuroepithelial stage all the way to terminal spinal motor neuronal differentiation.  
This gene lies near the Hoxc4/5 cluster and is annotated as both non- and 
protein-coding.  AK294004 encodes an antisense transcript that lies in the 3’ 
UTR of cyclin D1, a crucial cell cycle regulator.  Further analysis will be required, 
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both in understanding the importance of the transcriptional regulation pattern 
shown here, and in examining both the function of these gene products and their 
further post-transcriptional regulation. 
RNA-seq proved to be an extremely effective method for assaying 
patterns of alternative splicing, transcription initiation and polyadenylation.  We 
detected more than 75% of all known human alternative splicing events in at 
least one sample of our timeseries. We used custom-designed scripts and open 
source software to identify thousands of regulated alternative splicing events.  
We found that the “transcript diversity” -- that is, the extent to which genes are 
transcribed from alternative initiation sites, alternatively spliced or alternatively 
polyadenylated -- is highest in terminally differentiated motor neurons.  This 
finding is consistent with the vast majority of literature.  In almost all tested cases, 
we were able to confirm the detected changes through RT-PCR validation.  As 
noted above, RT-PCR is a significantly less sensitive method of analyzing 
expression, and thus, while the two methods demonstrated the same general 
trends in exon inclusion and initiation site usage, it was not surprising that the 
specific values associated with each developmental stage differed depending on 
the assay.   
One major benefit to genome-wide analysis is “strength in numbers,” or 
the ability to analyze huge groups of genes, in tandem, as opposed to a 
piecemeal approach to understanding the dynamic expression in differentiating 
cells. Through clustering of differentially spliced exons, we identified a subset of 
cassette exons exhibiting relative enrichment or depletion in spinal motor 
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neurons.  A small group of these is known to be regulated by the neuronal-
specific NOVA and FOX splicing factors.  Further work will be required to 
elucidate the regulatory mechanisms for the vast majority of observed differential 
splicing events.  We also attempted to analyze whether clusters of co-regulated 
genes showed transcription factor binding site enrichments. The UC-Santa Cruz 
Genome Browser has downloadable tracks of results from ChIP-seq experiments 
performed individually on 55 transcription factors.  This is far from a complete list, 
but we were able to compare the expression patterns of co-regulated genes with 
the binding sites of these transcription factors.  A number of different enrichments 
were found (for instance, the ~1,000 genes activated in late neuronal 
differentiation showed a significant enrichment for XRCC4 sites) (data not 
shown).  The expression levels of most of these transcription factors through the 
timeseries, however, are relatively even, so the pattern of dynamic expression 
could not be simply explained by a transcriptional increase in the transcription 
factors that could directly affect transcription of these clustered genes.  It must be 
noted, however, that transcription factors are heavily regulated at the protein 
level, through phosphorylation and other modifications.  It is highly likely that 
dyamic expression, and regulation, of scaffolding and protein-modifying 
complexes is a major factor in the activity levels of specific transcription factors at 
different stages of development.  Genome-wide proteomic studies would help 
elucidate much of the downstream regulation. 
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CHAPTER 3 
Differential Transcription and Alternative Splicing Patterns 
Between H9 and CT2 hES Cells: Establishing the Basal hESC 
Transcriptome 
 
Abstract 
 
 Human embryonic stem cells (hESCs) can be cultured with sustained 
pluripotency in three widely used conditions: 1) in unconditioned medium (UM) 
and on mouse embryonic fibroblast (MEF) as feeders, 2) in feeder-conditioned 
medium (CM) and on Matrigel, and 3) in defined medium like TeSR1 and either 
on Matrigel or xeno-free matrices like CellStart.  hESCs exposed to these 
different environments may be subject to a variety of epigenetic modifications, 
alterations of gene expression patterns, and selection pressures, which in turn 
may affect the efficiency and dynamics of the cell differentiation.  In comparison 
of the three conditions, TeSR1-cultured cells formed the lowest number of 
embryoid bodies (EBs) (which was reversed by a ROCK inhibitor), and EBs from 
CM-cultured cells had the earliest expression of differentiation marker genes 
(which was synchronized later) and the highest ratio of neural progenitors.  To 
address the culture-mediated alterations in hESCs, we analyzed the 
transcriptome profiles of two hESC lines H9 and CT2 cultured in the three 
conditions.  Despite great similarities in transcriptomes under all conditions, 
genes involved in BMP, TGFb, and FGF pathways were expressed lower, and 
genes involved in apoptosis and cell-cell contact expressed higher in hESCs 
cultured in TeSR1 than on MEF or in CM.  We also identified several cases of 
genes that were expressed exclusively in one cell line, but not the other.  We 
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observed very few robust alternative splicing differences between cell lines or 
culture conditions.  These findings suggest that, although hESC maintenance 
can be supported by the multiple culture conditions, the derivation efficiency, 
behavioral properties, and differentiation dynamics of hESCs are vulnerable to 
changes of the culture conditions, which coincides with transcriptome variations. 
 
Introduction 
Basic techniques for derivation and culture of human embryonic stem cells 
(hESCs) were first established in 1998 by Thomson and coworkers by using 
mouse embryonic fibroblasts (MEFs) as the feeder cells and carefully screened 
serum (Thomson et al. 1998).  Thereafter, numerous hESC lines were 
established in the feeder-coculture system (reviewed in Xu et al. 2001).  It has 
also been used for derivation of the later discovered human induced pluripotent 
stem cells (hiPSCs) (Xu et al. 2002; Xu et al. 2005; Xu et al. 2008)).  However, 
potential contamination by pathogens from the feeder cells remains to be a 
safety concern for application of the stem cells to clinic.  Also, the feeder-
coculture system hampers studies of molecular mechanisms involved in self-
renewal and differentiation of both hESCs and hiPSCs, due to the complex and 
undefined components that the feeder cells provide to the culture.  To remove 
the feeder cells, Xu et al. demonstrated that hESCs can be cultured on Matrigel, 
a gelatinous protein mixture secreted by mouse tumor cells and in MEF-
conditioned medium (CM) (Xu et al. 2001), which is now widely used for hESC 
and hiPSC culture.  Although it no longer needs co-culture with the feeder cells, it 
still has the safety concern and complexity of the components.  
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While seeking hESC-regulatory factors, it is known that BMPs induce hESC 
differentiation (Xu et al. 2002), whereas Noggin (a BMP inhibitor) and high-dose 
bFGF synergize to maintain hESC self-renewal (Xu et al. 2005).  Further, TGFb 
and bFGF work concertedly to inhibit BMP signaling, and TGFb-activated 
SMAD2/3 directly bind to the key pluripotency gene NANOG to regulate its 
expression (Xu et al. 2008).  In addition, WNT (Sato et al. 2004) and IGF 
(Bendall et al. 2007) pathways are also important to maintain hESC self-renewal.  
A defined medium TeSR1, which includes bFGF, TGFb1, and lithium chloride 
that activates WNT signaling, was formulated to derive and culture hESCs on 
defined matrices or Matrigel (Ludwig et al. 2006).  This medium was later 
commercialized with mTeSR1 as its trade name.  hESCs can be switched from 
the other culture systems to TeSR1.  Although teratoma formation in 
immunocompromized mice has proved the pluripotency of hESCs cultured either 
on MEF (Thomson et al. 1998), in CM (Xu et al. 2002) or TeSR1 (Ludwig et al. 
2006), it remains unclear whether hESCs cultured in the various conditions would 
behave similar when induced for lineage-specific differentiation in vitro, a critical 
step towards generating therapeutically desired cells for tissue repair or 
regeneration. 
Previous reports have indicated that ESCs cultured in various conditions 
respond to some growth factors differently.  For example, we have found that, 
unlike hESCs cultured on MEF or in CM, hESCs cultured in TeSR1 failed to 
differentiate to trophoblast in response to BMP4, due to the high concentration of 
bFGF (Xu et al. 2002).  Although mouse ES cells (mESCs) can also be cultured 
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in various conditions containing BMP + LIF or ERK inhibitor + GSK3 inhibitor, 
their germline transmission ability is lost when cultured with bFGF + Activin which 
supports hESC pluripotency (Chou et al. 2008).  Therefore, it is important to 
know whether the multiple culture systems can be used to equally derive hESC 
lines, and preserve their ability to differentiate to specific cell lineages without 
bias even after change from one culture condition to another.  Clarifying this 
question shall also help researchers to decide which culture system to use for 
specific research projects, in addition to economic and biosafety consideration. 
Here we have compared the gene expression profiles and differentiation 
properties of two hESC lines (H9 and CT2) in the three culture conditions: 1) in 
unconditioned medium (UM) and on MEF (UM/MEF, the traditional method), 2) in 
CM and on Matrigel (CM/Matrigel) or 3) in mTeSR1 and on CellStart, a xeno-free 
and defined matrix (mTeSR1/CellStart).  Differentiation efficiency and timing 
varied between hESCs cultured in the three different conditions, which correlated 
with gene expression profiles. These findings suggest that, although hESC 
pluirpotency is sustained by the multiple culture conditions, the derivation 
efficiency and differentiation dynamics as well as the gene expression profiles of 
hESCs are different in the various culture conditions.    
 
Results 
hESC lines can be derived in UM/MEF, but not mTeSR1/Cellstart nor 
CM/Matrigel 
 
To derive hESC lines under a defined condition, it was first tested whether 
the defined mTeSR1/CellStart condition indeed sustains pluripotency of hESCs, 
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which was confirmed by FACS analysis of the OCT4+ cell ratio among H9 
hESCs cultured in this condition for two passages (data not shown). 
Next, the defined condition versus the traditional UM/MEF condition for 
hESC derivation was tested.  Following an internal review board protocol, several 
2-8 cell stage human embryos were thawed, 16 of which developed to healthy 
blastocysts.  In the UM/MEF group, four inner cell mass (ICM) isolates from 12 
blastocysts attached well on the MEF feeders and survived as ICM outgrowths in 
the primary culture.  The ICM outgrowths were then replated onto new MEF-
coated plates, and all of them expanded and became stable hESC lines named 
CT1-CT4, and exhibited tightly packaged colonies with high nuclear/cytoplasm 
ratio (data not shown).  The new hESC lines were positive for the pluripotency 
markers OCT4, NANOG, SSEA4, TRA-1-60, and TRA-1-81 (Figure 3.1A).  After 
long-term culture, they maintained a stable euploid karyotype (Figure 3.1B) and 
formed teratomas in immunocompromised mice, which included tissues 
representative to three germ layers (Figure 3.1C). 
In the mTeSR1/CellStart condition, 2 of 4 ICM isolates from blastocysts 
attached well first, and the ICM outgrowths survived in the primary culture.  After 
replating, the ICM outgrowths formed colonies containing hESC-like cells on 
days 1 and 2.  However, the cells gradually detached and were lost on days 3-5, 
and finally the entire colonies disappeared (data not shown).  Failure to derive 
hESC lines also occurred in the CM/Matrigel condition (data not shown).  These 
data indicate that, although all the three conditions can maintain the routine  
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Figure 3.1.  Characterization of newly-derived CT2 human embryonic stem cell 
line.  (A) Immunocytochemistry studies on CT2 demonstrate that this cell line 
expresses the stem cell marker proteins OCT4, NANOG, SSEA4, TRA-1-60 and 
TRA-1-81.  (B) After long-term culture, these cells maintain a stable 23XX 
karyotype.  (C) Injection into immunocompromised mice leads to teratoma 
formation, including tissues representing all 3 germ layers. 
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culture of established hESC lines, only UM/MEF supports hESC derivation in 
these experiments and with the number of embryos used. 
  
Efficiency and dynamics of in vitro differentiation among hESCs and 
culture conditions 
 
Next, the Xu lab tested whether the different culture conditions would influence 
the differentiation efficiency of hESCs.  First H9 and CT2 cells were adapted from 
routine maintenance culture in UM/MEF to CM/Matrigel or mTeSR1/Matrigel or 
left in UM/MEF for at least 5 passages.  Next, the cells were removed from the 
dishes to start differentiation via EB formation in a suspension culture.  
Surprisingly, hESCs from the mTeSR1/Matrigel culture generated only about 
1/10 of EBs formed by hESCs from the UM/MEF or CM/Matrigel culture (data not 
shown), and most of the cell clusters formed by the mTeSR1-cultured cells 
degenerated on day one of the suspension culture (data not shown).  These 
could be improved by addition of the ROCK inhibitor Y27632 in the EB medium 
on day one. 
By using ABI Low-density Array real-time PCR card, expression of marker 
genes for pluripotency, trophectoderm, and the three germ layers in EBs formed 
by CT2 cells was tested by the Xu lab.  Pluripotency marker genes were down-
regulated, and differentiation marker genes up-regulated in day-7 EBs formed by 
hESCs cultured in CM/Matrigel but not UM/MEF or mTeSR1/Matrigel.  However, 
the changes of the gene expression were eventually observed in day-14 EBs 
formed by hESCs cultured in all the three conditions (data not shown).  These 
suggest that, given sufficient time in an identical culture condition, hESCs 
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previously cultured in various conditions can gradually synchronize to reach 
similar differentiation statuses. 
To further investigate whether the various culture conditions would affect 
lineage-specific differentiation from hESCs, the cells were differentiated into the 
neural (ectoderm) and haematapoetic (mesoderm) lineages.  During neural 
differentiation of H9 and CT2 cells by using an EB-based method (Zhang et al. 
2001), the ratio of PAX6+ neural progenitors gradually increased in all the groups 
with the highest ratio for EB cells formed by hESCs cultured in CM/Matrigel 
(Figure 3.2A).  H9 hESCs were co-cultured with OP9 stromal cells to induce 
hematopoietic differentiation.  After the 6-day coculture, the differentiated hESCs 
were collected and analyzed by FACS for ratio of CD34+ hemangioblast.  
Interestingly, no marked difference was observed among H9 cells originally 
cultured in the three conditions, and the ratios were around 4% for all the groups 
(Figure 3.2B).  These data suggest that the different hESC culture conditions 
only affect the subsequent differentiation of the cells into the neural but not 
hemangioblast progenitors. 
  
Transcriptomic variations were observed among hESCs cultured in the 
three conditions 
 
To investigate the molecular mechanisms responsible for the biological 
differences observed during derivation and differentiation of hESCs in the three 
culture conditions, we analyzed the global gene expression profiles of both H9 
and CT2 cells cultured in the three conditions for at least 10 passages using both 
microarrays and RNA-Seq.   Microarray analysis revealed that many genes  
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Figure 3.2.  Cells grown in the various culture conditions show similar patterns of 
differentiation with only subtle differences in their timing.  (A) Cells grown in any 
of the three culture conditions can be induced to form neuroepithelium when 
transferred into neural induction medium, and show similar proportions of PAX6+ 
cells after 14 days in culture.  (B) Cells grown in any of the three culture 
conditions can be driven into the hematopoietic lineage through co-culture with 
OP9 stromal cells.  The proportions of cells expressing CD34, a hemangioblast 
marker, are similar between cells originally cultured in any of the culture 
conditions. 
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involved in apoptosis were expressed higher, and many genes for ligands, 
receptors, transcription factors, and targets in the BMP, TGF-beta, and FGF 
signaling pathways were expressed lower in hESCs cultured in mTeSR1 than in 
CM or on MEF (data not shown).  Moreover, higher expression of genes involved 
in p53 pathway, actin cytoskeleton, tight junctions, and cell cycle, but lower 
expression of genes involved in steroid hormone synthesis, axon guidance, and 
gap junction were observed in hESCs cultured in CM than in the other two 
conditions.  
To achieve more in-depth transcriptome profiles of the variously cultured 
hESCs, we prepared RNA-Seq libraries in duplicate from both H9 and CT2 cells 
cultured 1) on MEF, 2) in CM, 3) in mTeSR1 or 4) reversal from TeSR1 to MEF.  
These libraries were sequenced on the Illumina Genome Analyzer IIx to generate 
single end reads of 76 bp.  We obtained between 39 and 69 million reads for 
each sample.  We simultaneously aligned the reads to the hg19 assembly of the 
human genome and a database of annotated splice junctions.  They resulted in 
between 27 and 44 million uniquely mapped reads per sample.  We then 
quantitated the expression level of all annotated genes and transcripts using 
Cufflinks.     
In both cell lines and across all culture conditions, there are 12,899-13,215 
genes expressed at FPKM≥1 (Fragment reads Per Kilobase of fragment model 
per Million mapped fragments, a normalized expression value).  Of these, 
approximately 50% are expressed at or above FPKM 10.  12,066 genes are 
expressed at FPKM≥1 in both cell lines across the three culture conditions (not 
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including reversal), representing 91-94% of genes expressed in any single 
sample (Figure 3.3B).   
The list of genes showing consistent changes across culture types, 
however, was much smaller.  Combining two culture types, at most 65 genes 
showed consistent changes.  Taking all three culture types into account, only 36 
genes showed consistent expression changes between H9 and CT2 ES lines 
(Figure 3.4A).  25 genes were upregulated (Figure 3.4B) and 11 genes 
downregulated in CT2 relative to H9 (Figure 3.4C).  These vast majority of these 
genes are "unclassified" by Panther pathway analysis, and no signaling 
pathways are represented.  Additionally, there are no enriched Gene Ontology 
terms associated with either of these groups of genes.   
We identified a small number of genes that were exclusively expressed in 
one cell line or the other.  CT2-specific genes included the maternally-imprinted 
gene Meg3 (Figure 3.5A), the divergently transcribed genes Cryz and Tyw3 
(Figure 3.5B), and a cluster of zinc finger nuclease genes on chromosome 
19p12 (Figure 3.5C). In contrast, other genes including Klf8 (Figure 3.6A), 
Znf558 (Figure 3.6B), and Best2 (Figure 3.6C) are expressed specifically in H9 
cells, but not CT2 cells.  Notably, H9 cells grown in MEF co-culture in another lab 
share the H9 expression pattern.  Klf8 encodes the Krüppel-like factor 8 
transcription factor, whose overepxression is known to drive oncogenic 
transformation through dual mechanisms of activation of cyclin D1 (Zhao et al. 
2003). It is not currently known whether the highly specific expression of these  
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Figure 3.3. Expression overview for H9 and CT2 hES cells growing in the three 
different culture conditions.  (A) Venn diagram representing the numbers of 
genes expressed at FPKM≥1 in H9 and CT2 cells growing in co-culture with 
MEF, on Matrigel with MEF-conditioned medium (CM), or on Matrigel with 
mTeSR1 chemically defined medium.  For example, to be placed in the MEF-
specific circle, a gene had to be expressed at FPKM≥1 in cells co-cultured with 
MEF and at FPKM<1 in both CM- and TeSR culture.  (B) Analysis of “robust” 
culture condition-dependent gene expression; the numbers represent genes 
expressed specifically in one or multiple conditions in both cell lines. 
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Figure 3.4.  H9- and CT2-specific gene expression analysis.  Individual sample 
gene FPKM values were standardized by Z-score to the average expression 
value across all samples and submitted for unsupervised hierarchical clustering 
via a complete linkage algorithm.  Heatmaps representing expression of genes 
expressed specifically in (A) either H9 or CT2, (B) CT2, and (C) H9 hESC.  
Yellow and blue colors represent high and low relative expression, respectively.  
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Figure 3.5. Examples of genes with highly enriched expression in CT2 hESC.  
Notably, these cells were also enriched in CT2 cells relative to a separate H9 
sample grown in MEF co-culture in another lab (H9 - MEF/JL) (A) The 
maternally-imprinted gene Meg3 is expressed highly in CT2 cells, but silent in H9 
cells.  (B) The Cryz-Tyw3 locus.  These two genes are arranged in a “tail-to-tail” 
arrangement and divergently transcribed.  Both genes are expressed at 
significantly higher levels in CT2 cells than in H9 cells, regardless of culture 
condition.  (C) CT2 cells specifically express a cluster of genes, including 7 zinc 
finger nuclease-encoding genes, along a ~1 Mb stretch of chromosome 19p12.  
This entire cluster is silent in H9 cells. 
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Figure 3.6. Examples of genes with highly enriched expression in H9 hESC.  (A) 
The transcription factor Klf8 is expressed highly in H9 cells, but silent in CT2 
cells.  (B) The putative transcription factor Znf558 is expressed in H9 cells, but 
silent in CT2 cells, regardless of culture condition.  (C) H9 cells express the 
transmembrane anion channel-encoding Best2, but this gene is silent in CT2 
cells. 
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genes is due to cell line-specific transcriptional differences or chromosomal 
aberrations.    
While dozens to hundreds of genes showed significantly differential 
expression in different culture conditions within an ES line (Figure 3.3A), we 
looked for consistent expression changes across the two cell lines to determine 
robust effects of culture type on transcriptome dynamics.  We found that, 
consistent with the microarray data, there were only a modest number of genes 
demonstrating differential expression in the different culture systems (Figure 
3.7A).  There were 22 genes that were expressed significantly lower in cells 
cultured with mTeSR1 than MEF (Figure 3.7B).  Pathway analysis revealed that 
these genes were predominantly associated with TGF-beta, MAPK/FGF, WNT 
and hedgehog signaling; a smaller set of 12 genes were expressed significantly 
lower in mTeSR1 culture as compared to both MEF and MEF-CM, with 
enrichment in the same signaling pathways.  Cells grown with mTeSR1 showed 
significantly higher expression of 12 genes compared with MEF-grown cells 
(Figure 3.7C); again consistent with microarray results, cell-cell adhesion and 
gap junction genes were represented, but we did not detect differential 
expression of genes involved in the apoptosis pathway.  Cells grown in co-culture 
with MEF are, on a transcriptome level, highly similar to those grown with CM.  
While we detected 66 and 92 differentially expressed genes between MEF and 
CM-cultured cells in the H9 and CT2 lines, respectively, only 4 of these genes 
were consistently expressed at significantly different levels in both cell lines.   
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Figure 3.7.  Culture condition-dependent gene expression analysis.  Individual 
sample gene FPKM values were standardized by Z-score to the average 
expression value across all samples and submitted for unsupervised hierarchical 
clustering via a complete linkage algorithm.  Heatmaps representing expression 
of (A) both TeSR-depleted and TeSR-enriched, (B) TeSR-depleted and (C) 
TeSR-enriched gene expression.  Yellow and blue colors represent high and low 
relative expression, respectively. 
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Furthermore, only 2 of these genes showed consistent effects of culture condition 
on expression level. 
The reversal condition expression data reinforce findings from the 
comparison of MEF and mTeSR1 culture systems.  15 genes were expressed 
significantly higher in both MEF and Reversal conditions than in mTeSR1 -- this 
implies that these genes are "plastic" in their expression, i.e. expression is both 
dictated by the environment in which the cells are grown and labile to changing 
conditions (Figure 3.8).  This list of genes included elements associated with the 
signaling pathways identified above (TGF-beta, MAPK/FGF and WNT).  Only 1 
gene, Ptch1, involved in hedgehog signaling, showed lower expression in MEF 
co-cultured cells than either TeSR or Reversal conditions in both cell lines, 
indicating that expression of Ptch1 is dictated by culture environment, but is not 
plastic -- the effects of culture type on expression may not be reversible (Figure 
3.8D).  Genes whose expression was increased in culture on Matrigel with 
mTeSR1 included Tnik and Kdr (Figure 3.8E).  Kdr is also known as Vegfr2, an 
important receptor for VEGF, a pro-angiogenic factor (Larrivee and Karsan, 
2000). 
These transcriptome-profiling data suggest that, although expression of 
pluripotency genes is maintained, differential expression of genes involved in 
cellular structures and functions and the key signaling pathways may be 
responsible for the above-described variations in derivation and differentiation of 
hESCs in the three conditions. 
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Figure 3.8.  Examples of culture condition-dependent gene expression.  
(A)  Culture condition-dependent expression pattern of Bmp4.  Expression is 
decreased dramatically in culture on Matrigel with mTeSR1 medium.  
Notably, the reversal condition resembles the MEF/CM state, indicating 
that the culture condition-induced expression pattern of this gene is 
reversible.  BMP4 is an important member of the TGF-beta signaling 
pathway.   
(B)  Culture condition-dependent expression pattern of Fgf4, which 
demonstrates a pattern similar to that of Bmp4.  The culture-induced 
change in Fgf4 gene expression is reversible.  The FGF4 protein is an 
important member of the FGF signaling pathway.   
(C)  Culture condition-dependent expression pattern of Id1.  The TeSR culture 
condition-induced depletion of gene expression is reversible.  Id1 encodes 
a bHLH transcription factor involved in BMP signaling (Hayashi et al. 
2007).   
(D)  Culture condition-dependent expression pattern of Ptch1.  In this case, 
expression in MEF co-cultured cells was significantly higher than in the 
reversal condition, indicating that the TeSR-induced decrease in Ptch1 
expression may not be reversible.  Ptch1 encodes the patched 1 homolog 
protein, a receptor in Notch signaling. 
(E)   Culture condition-dependent expression pattern of Kdr.  Kdr expression is 
increased in culture on Matrigel with mTeSR1 medium.  The reversal 
condition resembles the MEF conditions – this effect is more apparent in 
the CT2 line, where expression in the reversal condition has been reduced 
significantly from the level in TeSR-grown cells.  In the H9 reversal 
condition, expression is somewhat lower than in mTeSR, but is higher 
than in MEF/CM conditions.  Kdr encodes the kinase insert domain 
receptor, also known as VEGF receptor 2, a receptor for VEGF signaling, 
a signaling pathway with a major role in angiogenesis. 
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Analysis of alternative splicing 
 We next determined if there were any alternative splicing events that were 
differentially regulated either between the two cell lines or among the various 
culture conditions.  To do this, we used MISO (Katz et al. 2010) to calculate the 
percentage spliced in (PSI) for all ~100,000 splicing events described in Wang et 
al. 2008 for all 8 samples.  Interestingly, we detected the expression of ~72,000 
splicing events in at least one sample.  Though we identified between 575 and 
1,251 splicing events that differed between H9 and CT2 cells in one of the four 
different culture conditions, only 16 events in 9 genes were differentially spliced 
in all four conditions (Table 3.1).  Moreover, the magnitudes of splicing changes 
among these events were not dramatic.  Perhaps the most convincing difference 
is a cassette exon in the SNURF-SNRPN gene that is more frequently included 
in CT2 cells than H9 cells (Figure 3.9).  
 We also examined splicing differences within each cell line but between 
the various culture conditions.  This analysis identified 1,012 events in H9 cells 
and 2,351 events in CT2 cells that were differentially spliced between any two of 
the three standard culture conditions (not including reversal).  Moreover, only 160 
events were common to both cell lines.  Again, the magnitude of these splicing 
changes was on the whole not dramatic.  Based on these observations, we 
conclude that there are few, if any, robust and reproducible splicing differences 
between H9 and CT2 cells or between the various culture conditions.  Thus the 
majority of the transcriptome differences between these cells and culture 
conditions are due to transcriptional differences rather than splicing differences.  
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Table 2.1.  Summary of MISO analysis for hESC line and culture condition 
comparison.  We analyzed 108,354 splicing events identified in Wang et al. 2008.  
We detected 71,959 events in at least one sample.  We compared the splicing 
patterns between H9 and CT2 hES cells and among the three culture conditions.  
(A) We identified between 575 and 1,251 splicing events that showed different 
patterns between H9 and CT2 cells grown in any individual condition.  However, 
we only identified 16 events in 9 genes that were differentially spliced between 
the cell lines in all four culture conditions tested.  Moreover, the magnitudes of 
splicing changes were not dramatic.  (B) We identified 1,012 splicing events in 
H9 and 2,351 events in CT2 cells that showed different splicing patterns between 
any two of the three main culture conditions (MEF, CM, TeSR).  However, only 
160 of these events were different between the given culture types in both cell 
lines.  Furthermore, the magnitudes of splicing pattern differences were not 
dramatic. 
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Figure 3.9.  Identification of a differential splicing pattern between H9 and CT2 
hES cells.  This cassette exon within the Snurf-Snrpn gene, identified by MISO, 
is included more frequently in CT2 cells, regardless of the culture condition. 
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Discussion 
 
 It is well known that human embryonic stem cells can be grown and 
maintained in three different culture systems: in unconditioned medium in co-
culture with MEF cells, in MEF-conditioned medium on Matrigel matrix, and in 
mTeSR1 chemically defined medium on Matrigel matrix.  However, it was unclear 
whether the systems involving growth on Matrigel (or other commercially 
available matrix systems, like CellStart [Invitrogen, Carlsbad, CA]) would support 
derivation of new hESC lines.  Additionally, it was not known whether these 
alternative culture conditions affected transcriptome expression or differentiation 
capabilities and characteristics of the cells. 
 Here, we have described the attempts (by the Xu lab) to derive and 
characterize new hESC lines on each of the culture systems.  They found that 
the alternative culture conditions (with CM and mTeSR1) did not support the 
derivation of hESC lines.  Cells grown in mTeSR1 on Matrigel were less apt to 
form embryoid bodies when grown in low-attachment conditions, an important 
method for generating differentiated cells of multiple lineages.  Further, the Xu 
lab observed subtle differences in the timing of differentiation between cells 
grown in the various conditions (Xiaofang Wang, personal communication).   
 We used microarrays and RNA-Seq to examine the gene expression and 
alternative splicing patterns of the widely-used H9 and newly-derived CT2 hESC 
lines.  We found that the vast majority of genes are expressed at similar levels 
between the two cell lines and among the various culture conditions.  Our RNA-
Seq analysis identified 36 genes expressed at significantly different levels 
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between H9 and CT2 cells.  Although these groups of genes did not show 
enrichment in any known signaling pathways or cellular functions, there are a 
number of transcriptional regulators, including Klf8 and several zinc finger 
nuclease proteins, represented.  Further work will be required to understand the 
biological relevance, if any, of these differences in gene expression.  Additionally, 
we identified 22 genes that are depleted in expression in cells grown in mTeSR1 
relative to co-culture with MEF (15 of these are also depleted relative to reversal 
condition, and 12 are depleted relative to cells grown with CM).  This set of 
genes includes factors involved in TGF-beta, FGF and WNT signaling pathways.  
These pathways are all important in differentiation, and thus may explain the 
differential developmental characteristics of cells grown in the different culture 
conditions.  A set of 12 genes are enriched in expression in cells grown in 
mTeSR1 relative to those grown in MEF co-culture.   
 We also investigated the alternative splicing patterns of the two cell lines 
and the different culture conditions.  Although we detected, in at least one 
sample, almost 75% of all known splicing events in the human genome, there 
were very few that were spliced in significantly different patterns between the two 
cell lines or among the various culture conditions.  We conclude that the subtle 
differences in cell differentiation and growth characteristics observed between 
cell lines and among culture conditions is more dependent on differences in gene 
expression than in alternative splicing patterns. 
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Experimental Procedures 
Derivation and culture of human embryonic stem cells 
Human embryos were donated for the study after obtaining written 
informed consents from the patients undergoing assisted reproductive 
technology treatment and approval of the Connecticut ESGRO ethical committee. 
These embryos were cultured to blastocyst stage in Quinn’s Advantage 
Blastocyst medium (CooperSurgical). Then, blastocysts were mechanically cut 
into half and the half with ICM were cultured on mitotically inactivated mouse 
embryonic fibroblasts (MEFs) in unconditioned hES medium, which containing 
DMEM/F12 supplemented with 20% knockout serum replacement, 2mM 
nonessential amino acids, 2mM L-glutamine, 0.1mM β-mercaptoethanol and 
4ng/ml of basic Fibroblast Growth Factor (bFGF) (all from Invitrogen). When the 
trophoblasts spread out and the ICMs outgrowth became distinct, they were 
manually picked and replate on fresh MEFs. Once established, the hES cells 
were passaged every 7 days for long-term propagation.  Alternatively, the cut 
blastocysts with ICM were plated on Cellstart (Invitrogen) in mTeSR1 medium 
(StemCell Technology) for derivation as described above.  Both CT2 cells and 
H9 cells were routinely cultured in three conditions for follow-up comparison 
experiments. CT2 cells and H9 cells were initially cultured in un-conditioned 
medium (hES medium) on MEFs, and passaged by mechanical cutting every 7 
days.  Colonies of H9 cells and CT2 cells were transferred into feeder-free 
conditions, in conditioned medium or mTeSR1 on matrigel, and passaged by 
dispase every 4-5 days. 
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Spontaneous and induced differentiation of human embryonic stem cells 
The spontaneously differentiation of CT2 and H9 cells in three conditions 
were initiated by suspension culture of hESC clumps dissociated by dispase in 
ultra-low attachment flask to form EBs in hES medium minus bFGF, with 
supplementation of 10 uM ROCK-inhibitor when making EBs from hESCs from 
mTeSR1/Matrigel at day 1. The medium was changed everyday and d3, d7 and 
d14 EBs were collected for further gene expression analysis. To induce neural 
differentiation, H9 and CT2 cell clumps were cultured in suspension to form EBs 
as described above for 4 days, then EBs were transferred into neural induction 
medium, which consisted of DMEM/F12, 1% N2 supplement, 1% Non-essential 
amino acids, 2 ug/ml Heparin and 10 ng/ml bFGF, and cultured in suspension for 
another 6 days. Then the EBs were transferred onto gelatin coated 6-well plate 
for attachment and cultured for another 4 days in neural induction medium. The 
neural induction medium was changed every other day. D7 and d10 EBs and d14 
attached EBs were collected for FACS analysis. 
  
Immunocytochemistry and FACS analysis 
For immunocytochemistry, hESCs were fixed in 4% paraformaldehyde at 
room temperature for 20 minutes, then blocked with 4% goat serum in PBS and 
incubated with primary antibodies diluted in blocking solution overnight at 4°C. 
For intracellular antigen, cells were permeabilized for 10 minutes in 0.1% Triton 
X-100 before blocking. The following primary antibodies were used: Mouse anti-
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SSEA3 and mouse anti-SSEA4 (from Developmental Studies Hybridoma Bank, 
DSHB) antibodies, Mouse anti-TRA1-60, mouse anti-TRA1-81 and mouse anti-
OCT-3/4 (C-10) (from Santa Cruz Biotechnology Inc.), and rabbit anti-NANOG 
antibody (Abcam Inc.) for characterization of undifferentiated molecular markers 
of hESCs. Unbound antibody was removed by extensive washing, and 
localization of antigens was visualized by using Alexa Fluor 488 secondary 
antibody (Molecular Probes, Inc. 1:1000). Nuclei were counterstained with DAPI 
(Sigma; 1:1000). 
For FACS analysis, cultured EBs were digested by Accumax solution 
(Innovation Cell Technologies, Inc.) into single cells and washed once in FACS 
buffer, then fixed with 0.1% paraformaldehyde for 10 minutes and subsequently 
permeabilized with 90% methanol for 30 minutes on ice.  Next, 1x106 cells were 
resuspended in 1ml FACS buffer with 1 µg/ml mouse anti-PAX6 antibody (from 
DSHB) or mouse IgG isotype antibody (Abcam) for overnight culture at 4°C and 
followed by incubation with Goat anti-mouse IgG 488 (1:1000 in FACS buffer) for 
2 hours at 4°C. Cells were washed three times with FACS buffer and once with 
PBS before FACS analysis. 
 
Gene expression analysis 
To compare the gene expression profiling of H9 and CT2 cells in three 
conditions, hESCs were adapted to each conditons for at least 5 passages and 
then collected. Duplicate samples were collected in each group and RNAs were 
extracted by RNAqueous®-4PCR Kit (Ambion). RNAs were sent for Illumina 
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Bead Expression Array and Solexa Sequencing. Array data were processed by 
Beadstudio software and further normalized and analyzed by Cluster, Treeview 
and functional annotation program (http://david.abcc.ncifcrf.gov/home.jsp).  For 
EB differentiation assay, both H9 and CT-2 EBs from d3, d7 and d14 culture 
were collected. RNA was isolated by RNAqueous®-4PCR Kit and went for a 
panel of undifferentiated and differentiated cell marker genes analysis using the 
ABI pluripotency low density array kit. 
  
RNA-Seq library preparation 
 
For each sample, 2 biological replicates were used to make RNA-Seq 
libraries.  To collect RNA, cells from culture dish wells were treated with 1 mL 
TRIzol reagent (Invitrogen). Total RNA extracts were treated with DNase and 
analyzed by Nano-drop spectrophotometer and run on a 2% agarose gel to 
ensure quality.  10 ug of total RNA from each sample were used to construct 
cDNA libraries using the Illumina mRNA-Seq sample preparation kit. Briefly, 
poly(A)+ RNA molecules were isolated through 2 rounds of selection with oligo-
d(T) beads. The RNA was then chemically fragmented, precipitated, and reverse-
transcribed to form double-stranded cDNA. End-repair, addition of an adenine 
nucleotide, and paired-end adapter ligation were then performed and adapter-
ligated libraries were gel-purified (isolation of ~300 bp fragments). PCR was then 
performed to amplify the cDNA constructs, and libraries were again gel-purified.   
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Sequencing & Data Analysis 
Libraries were clustered onto flowcells and single-read, 76-bp sequencing 
was performed using the Illumina Genome Analyzer IIx. Raw sequence reads 
have been deposited into GEO (Accession number XXXXXX).  Bowtie 
(Langmead et al. 2009) was used to simultaneously align 75-bp reads trimmed 
from the 3’ end to a combined index of the human genome (2009 release 
(hg19/GRCh37)), and all annotated splice junctions in hg19.  The splice junction 
index was created by extracting exonic sequences from UCSC, via Galaxy 
(http://usegalaxy.org), and assembling them into exon-exon junctions consisting 
of 69 nt of each joined exon, ensuring a minimum of 6 bp overlap during the 
alignments. Reads that mapped uniquely, with up to 2 mismatches, were 
accepted for downstream analysis. Custom perl scripts were used to convert 
Bowtie outputs into sam format for gene and transcript quantitation using 
Cufflinks (Trapnell et al. 2010). Cufflinks outputs were converted into tables 
representing gene-, transcript start site-, and transcript-level expression values 
(“FPKM,” or Fragment reads Per Kilobase of fragment model per Million mapped 
reads) with respect to all genes (26,702) across all samples in the neuronal 
differentiation timeseries.  Global gene expression profiles were compared, pair-
wise, between all sequenced lanes, and Pearson correlation tests performed. 
 Lanes showing Pearson R2 ≥ 0.95 were merged into final sample datasets; 
these compiled reads were then re-aligned and analyzed using the methods 
described above.  Genes were considered to be “expressed” only if at least one 
sample scored FPKM ≥ 1.0.   
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Next, Cuffdiff was used to detect significantly-changing genes and 
transcripts between the two cell lines and among the various culture conditions.  
Expression values were further standardized by “Z-Scoring” sample FPKM 
values with respect to each gene’s average FPKM across all samples.  
Dendrogram “heatmaps” were created using the free software Cluster 3.0 
(EisenLab). 
To examine patterns of alternative splicing, we used the Mixture of 
Isoforms (MISO) software (Katz et al. 2010), available from the Burge Laboratory 
(http://genes.mit.edu/burgelab/miso/), to analyze ~100,000 splicing events in the 
human genome, as identified in Wang et al. 2008.    
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 CHAPTER 4 
A Summary of Findings, Conclusions and Prospects for Future 
Research 
 
Human embryonic stem cells (hESC) have tremendous potential for 
research and medical fields.  hESC culture represents an ideal system for 
studying development of complex tissues, and is, for all practical purposes, the 
only system available to study fetal developmental processes in a human setting.  
There is great excitement for hESC-based transplantation as a tailored therapy 
for previously intractable conditions. The current model for therapy is to 
differentiate hESC into progenitor cells of the tissue of interest, and to transplant 
those cells into the damaged area, where they respond to physiological signals to 
migrate and terminally differentiate into the damaged tissue type.  This could be 
especially useful in the central nervous system; although there are areas of 
neurogenesis in the adult brain, these are highly limited in potential.  Thus, the 
body can generally do very little to combat neurodegenerative conditions.  
Further, while we could potentially use stem cells to re-grow entire organs in a 
lab, there are perhaps even more possibilities for regenerative medicine using 
induced pluripotent cells (iPSC).  Using iPS technology, one could imagine 
banking individualized stem cells for use in transplantation therapy to replace 
cells lost to any given pathology.  It is extremely important, however, that we 
develop a full understanding of these cells and their characteristics before we 
begin using them for such purposes.  Notably, stem cells share many 
characteristics with certain types of cancerous cells.  Indeed, stem cells are 
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highly proliferative, and thus tight control over their behavior is crucial to 
therapeutic use.  Further, the most common system for growing and maintaining 
hESC in culture involves co-culture with mouse embryonic fibroblasts (MEFs), 
and it is important to note that any cells to be used for transplantation must be 
maintained in xenobiotic-free environments.  Accordingly, feeder-free culture 
systems have grown in popularity and in use in research.  It is important to 
understand the differences, if any, between hESC grown in the different culture 
systems. 
The goals of my project were the following.  First, I wanted to characterize 
the “baseline hESC transcriptome” – to catalog the gene expression milieu 
common to human embryonic stem cells.  While there have been attempts at 
characterizing the gene expression patterns in hESC, most of these had used 
microarray technology.  I, however, chose to use RNA-Seq and thus undertake a 
much more powerful, and sensitive, analysis.  Additionally, using RNA-Seq 
instead of microarrays allowed me to investigate patterns of alternative splicing in 
ways that I never could with microarray.  I accomplished this by establishing a 
collaboration with the UConn Stem Cell Institute.  I obtained RNA samples from 
biological replicate samples of H9 (an extremely commonly used hESC line) and 
CT2 (recently derived at the University of Connecticut) hES cells growing in the 
three major ES culture systems: co-culture with MEFs, growth on Matrigel with 
MEF-conditioned medium (CM), and growth on Matrigel with chemically-defined 
mTeSR1 medium.  It was not previously known if cells growing in these different 
culture conditions were equivalent on a transcriptome level. 
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The gene expression patterns of these two stem cell lines proved to be 
extremely similar.  The vast majority of genes (>90%) expressed in any cell 
line/culture condition pairing were expressed by both cell lines and across all 
culture conditions.  I identified 36 genes demonstrating significantly different 
expression between the two cell lines.  There were no enrichments in any cellular 
functions or signaling pathways among the differentially expressed genes, but 
there were a number of transcriptional regulators among these genes, including 
some with known function (e.g. Klf8) and many that require further investigation 
(including several zinc finger-containing proteins).  Additionally, there are a 
number of genes that have only been described in EST experiments, have no 
known orthologues in other organisms, and have no previously known function.  
Further experiments are needed to elucidate the biological relevance, if any, of 
these genes.  There were only 36 genes expressed at significantly different 
levels between the culture conditions.  All but 2 of these differences were 
observed between cells grown in MEF co-culture and those grown with mTeSR1 
medium.  Cells grown in culture with mTeSR1 were depleted in genes associated 
with TGF-beta, FGF and WNT signaling pathways, while mTeSR1-upregulated 
genes included some involved in cell-cell adhesion and gap junctions.  More than 
half of the genes whose expression was depleted in mTeSR1 cells relative to 
MEF cells also showed depletion relative to the reversal condition.  This implies 
that, for most genes that show culture condition-influenced changes in 
expression, the changes are plastic – that is, expression differences due to 
environmental exposure are reversible. 
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I also studied the patterns of alternative splicing (AS) in these cells, and 
found that the cells are even more similar in terms of AS patterns.  I detected 
almost 75% of all known splicing events in the human genome.  While there were 
between 500 and 1,200 splicing events that showed different splicing patterns 
between individual H9 and CT2 samples, there were only 9 splicing events that 
showed consistent changes in splicing patterns in all four culture conditions 
tested.  Furthermore, the magnitudes of change in these events were not 
dramatic.  It appears that the subtle differences in growth and differentiation 
characteristics seen between cells grown in different culture conditions is due 
more to differential gene expression than to differential alternative splicing 
patterns. 
Next, I wanted to analyze the patterns of differential gene expression and 
alternative splicing as hES cells differentiate into spinal motor neurons.  To 
accomplish this goal, I used RNA-Seq to analyze the mRNA populations in cells 
along the course of development from undifferentiated H9 hES cells to fully 
mature neurons.  For this experiment, I collaborated with Dr. Xue-Jun Li, an 
expert in neural differentiation of stem cells.  Dr. Li provided RNA samples from 8 
different cell populations, representing 6 different developmental stages.  
Analysis of stage-specific marker genes validated our dataset as accurately 
reflecting the given samples.  In contrast to the comparison between hESC lines, 
the neural timeseries data showed dramatic patterns of differential gene 
expression.  I identified thousands of genes that were expressed at significantly 
different levels between any two samples, including hundreds whose expression 
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significantly increased or decreased across each developmental transition.  
Unsupervised hierarchical clustering provided me with groups of genes to 
analyze in tandem.  Analysis of co-regulated genes revealed the coordinated 
action of multiple signaling pathways, including WNT, BMP, FGF, Notch, integrin 
and cadherin signaling, in the process of neural differentiation.  Indeed, many of 
these pathways showed complex patterns, possibly implying that they play 
distinct roles in early and late neural differentiation.   
In addition to the dramatic changes in gene expression, I performed 
analysis of alternative splicing events.  I analyzed over 108,000 splicing events in 
the human genome, and detected over 75% of all events in at least one sample 
along the timeseries.  Of the detected events, I identified almost 9,000 AS events 
that showed significant change between any two samples.  The splicing patterns 
were most highly similar between cells at similar developmental stages, and the 
greatest difference in AS patterns was observed between H9 and MN cells.  I 
selected a subset of identified AS events to validate by RT-PCR, and 
successfully validated the splicing changes observed in RNA-Seq analysis in 
over 90% of the events tested. 
There are almost limitless directions to go with the data I have generated.  
A number of useful and interesting experiments come to mind.  One could pick 
out the transcription factors whose expression significantly changed along the 
timeseries, and perform ChIP-Seq to determine the transcriptional targets of 
these factors.  Similarly, one could identify chromatin-remodeling factors with 
dynamic expression during differentiation and study the specific chromosomal 
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regions targeted by these proteins using ChIP-Seq.  For RNA-binding proteins, 
one could perform RNA immunoprecipitation (RIP) or cross-linking 
immunoprecipitation (CLIP), followed by sequencing, to identify the protein’s 
genomic “footprint.”  If an RNA-binding protein is identified as a splicing factor by 
CLIP-Seq, one could perform RNAi to knock the gene’s expression down, and 
examine the resulting splicing pattern.  Hundreds of the identified genes with 
dynamic expression patterns across the timeseries have unknown function.  To 
develop a basic understanding of these genes’ functions, one could search their 
protein sequences for conserved domains; if there are DNA-binding domains, 
one could raise antibodies against the protein and perform ChIP-Seq.   
There is an abundance of evidence that epigenetic modification plays a 
major role in silencing and activating genes at appropriate stages of neural 
differentiation.  RNA-Seq only detects mRNA-level events.  Therefore, absence 
of signal in RNA-Seq does not yield any information as to the regulating event 
behind that silence.  It would be very interesting to pull down chromatin by 
immunoprecipitation (ChIP) with antibodies against activating (e.g. H3K4me3) or 
silencing (H3K27me3) epigenetic marks to examine genome-wide patterns in 
cells at various developmental stages.  
MicroRNA regulation is also known to be important in the context of stem 
cell self-renewal and differentiation.  Small RNA-Seq is a powerful method for 
elucidating the catalog of miRNA molecules active in any given tissue.  This 
information can be combined with mRNA-Seq data regarding 3’ UTR dynamics to 
understand the functional consequences of alternative polyadenylation site and 
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3’ exon choice.  Unfortunately, the bioinformatics side of this type of analysis 
leaves much to be desired, as it is often difficult to identify miRNA targets based 
solely on RNA folding models and seed sequences.  One way to circumvent the 
sub-optimal target prediction programs is to use antibodies against protein 
elements of the RNA-induced silencing complex (RISC).  In this way, one can 
purify proteins bound to specific miRNA:mRNA duplexes, identifying specific 
miRNA targets without the ambiguity associated with computational predictions.  
One could also attempt to understand the dynamics of transcription factor-
DNA interactions at different stages of differentiation.  Maps of transcription 
factor binding sites are available online; it would be interesting to examine 
whether known transcriptional targets follow the expression patterns of the 
transcription factors responsible for their expression.  This analysis should ideally 
be combined with proteomic studies of transcription factor modifications, as post-
translational modifications are known to be extremely important in regulating 
transcription factor activity. 
The raw sequence reads can be used to study patterns of RNA editing.  
Editing is the process by which ADAR (adenosine deaminase, RNA-specific) 
converts adenosine to inosine.  Inosine residues are read by the sequencer as 
G’s.  By scanning reads and comparing them to the consensus genomic 
sequence, one can look for A/G mismatches.  While some of these will be due to 
simple sequencing errors, the majority of mismatches will be due to RNA editing.  
By examining the “pileup” of multiple reads over a single event locus, one can 
rule out sequencing errors by the ratio of reads containing A’s to those containing 
 200 
G’s.  A low proportion of G reads would indicate sequencing errors as the source; 
higher proportions of G-containing reads would imply a real editing event. 
In my experience, RNA-Seq has been an excellent method to study the 
patterns of alternative splicing, across samples, for individual splicing events.  
Perhaps the most vexing aspect of this project, however, was my inability to 
study the dynamic patterns of expression of entire transcripts.  This is a problem 
inherent to the current generation of sequencing technology.  These machines 
are geared toward generating millions of short reads, which allows for an 
incredible depth of study.  Most mRNA molecules, however, are hundreds to 
thousands of nucleotides in length, so most reads cover one or two exons, at 
most, and can’t come close to spanning entire transcripts.  This could be the 
greatest advantage of next-next gen sequencing.  Many groups are working on 
technology for single-molecule sequencing, whereby a DNA or RNA strand is 
rapidly “pulled” through a sensor and sequenced in real-time.  The ability to 
simultaneously study multiple splicing events at once would remove one of the 
most frustrating barriers to understanding RNA processing. 
 In short, the data presented here represent a useful resource for anyone 
working in the fields of human embryonic stem cells and/or development of the 
central nervous system.  I have learned an immense amount about these 
processes, and developed a very healthy respect for gene regulation.  The 
interplay of factors acting to modify chromatin, access gene promoters, select 
transcription initiation sites, ensure the proper constitutive and alternative splicing 
patterns, and properly process the RNA to set the stage for appropriate 
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downstream regulation in each particular cell and tissue type is truly astounding.  
It will be exciting to continue to follow the field as we grow our understanding of 
the global events governing stem cell self-renewal and differentiation. 
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